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study ' was made · of the.A ~mpa:rative
{
.~
":1' r~.pe~ively, Compal'!'.on · 'of . Ihe,.· ~~~' . ' ~equencc' .bomologies~ of : :~
, the viral , enhancers indica~es Qlat the ' ~~ 16 and. \ 18 ,' e~~ncet . . - ~~
elements , ~ closer ' ' ~ - .seq~ence . , homolo~. · - than-= e,~~er-~vf15·-.-, :,~
or 18 is to, the HPV .]l enhancer, Enhancer activity of ' the. ncr - . ~
. of . these viruSes was testCd ' for '. expreisio'n in :. seve~ cerViCal :;~
and nonceryical cell ~nes. The . ~uence relatedness ()~ thes~ '. " ~
HPV . ncrs cor~eS~nds " ~,~ th~ dirference~ ' !n. · ' cell speci.ficities. . ~,
observed · among the HPV- '16,' .18,. and 11' enhancer ::elements.. ', i "
../}
HPV ' 16 and . 18 enhancer activity, is .restr icted t~ cervical / ,':'i
e~i.theli~ cells, .whereas ' .the .' HPY 11· ' enh8n~r, appears ' to ' .be I . . .
active in a wider range of ~U · '~es, The. conditional .. enhancer /
,
.. -
- (
/
enh';"cers/p~mo!ers) of .human " p~pillo~a~!,US . J HPV) 't)'pCs 16-
18, and. . 11, This .was ~ccOmplished by inserting , " th~ nOnCoding "
regi~n (n~) fragmen~ ' of ,cacb virai type imm~tely upstream
of the . chlor amphenicol acetyltransferase. '(CA!>' ;' gene '. in the
. j,sVo-cAT plasmid' to test foI:. 'pronio'ter function and i!)to the
enh~nce~l~ PAlO·....· CA~ plasmi4 ' to~r test ·(or ' . inhan~r. function"
, ~ , this manner, the ' . n~nCoding r;;gitns of HP~ i 16, 18,'·.· and . 11
_,_ . " l . .
were shown to contain enhancer and/or prq.m~i~r function. ' In
.addition.·- the ' constitutive ( enhancers of lJPV. ."1-6;~ ' 18, ,, and .11-.
. , were I~ to '315 bp,' 230 bp, and '2~~ bp ( fntgments,
;., \ .
and ' is- _repressed ..,~
Trans-ectlvation n i~_,- , 'medi,atecl.- .
~ .binding ' . motif < on , HPV · enhancer plasmids with .
: 8 . heterologous but not with a hO~OI~rUS promoter ,'
"
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which " can '
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recen t
lesions
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IN1RODUcroN
)
are- 'known .to " be as:sOCiate~ .. wit~ ~ cervical '
progr~ss _.. l~ " .ma lign ant car cin omas .~~h!s
Papillomavir uscs .
, .
whic~ cause' "beni gn cp~lial , tumors or ,m in humans and
in a varlc,ty~" aDimaJ species .(zu~ Hawcn.> · 1m ; 1.Jl.llca::ter . ,
.and ",'Olson, ..~1982): A subgroup of the , hum~ ~ papillomaviruses
~.V ~s ' 6 ' arid ~ 1) arc essocieted. ~h benign ' lesions of
.ex1c"!aJ. genitalia while" ,the HPV types 16, 18, 31, 33, and 3S
. is, ' 18,' .end 11. " Special " 'emphests : has been placed on the .cell
,~.. · ~pCcifi.~ty . 'of , the HPy enh~C:r ·clements. This wOJ:k ats6
, deals " with, . the res:wJation of enhancer. and promo~er ' elements
HPV ) 6, : IS. and' · ' 11' by ce~in ' viral (HPV ·16) . gene
berv.ttD ." HPV ~ ;, 16 and ' 18 , . and -humen . cervical carcln~mas
~ : . s~ .~ great . ' d~ 'of interest "'}~dy. the molll:uIar
biology of ,' these viruses . Th e initial ' step in studying the
. .' . .. .
molecular . genet ics of ihese "viruses .was • achieved by cloning
, and s~quen~ing DNA isolat ed from var ious papillomatous
. . t issues• .~ ' S'ubseq~~nt investigations · have concentrated mainly on
tbe .
members of,
mouse , pol yoma virus,
,
Pepi tlomav iru se s are . cl assif ied
pap ovavirus _ family a long with the
monkey ·....simian vacuolating ' virus . 40 (SV40). and "ihc human OK
~nd ' 1C viruses (Melnick. 1962; Melnick .c.1 .D1 ' 1974). J'he
genomes of papillomaviruses consist. of~ "closed circular double-
stranded DNA molecules which ' ere conside rably. larger dian
th at of po lyom.8viruses (approximately 7900 bp . versus
approximately 5250 . bp). Fu~therQl~r~ ~1hc .genomes of the
. papillomavirus . and SV4~/poJyo~a,?rus groups .bear virtually' no
' similarity, in: .their '. gene tic 'organization or' sequence- .: In the .
" '. , . /. .
past, papillcmaviruses . have received little ". auemion in terms
of : moiecuIar, "virology ·. due to -' lack of host v eeus .
s!pport tile' propagation of ) these . viruses .-- in culture. Using
~ . .
recombinant DNA .technology, . are beginning . to understand
ho=-" the papill om aviru s genome is otganized, expressed, and
.. regula!~
.. DNA ~equente . 'data '<.ef ten different ' . paplllomavirus es have
shown a notably ' . uniform . nrganizaticn of - ' the viral genome.
Most of the . major open reading frameS; (OR Fs; putative
protein coding sequences) . are located in si11'iil~ r positions .and
a~ ar"e . l0c8ted on Ii single. strand of ~ vimt DNA in the same
dire ction•. . Until rece~tly. · functional analysi~ of ~~Pilloma\irUS'
· ' s tud y
t ra nscri p ts
, ~
from produ.ctively infected ~Jls
" of th~ viral-ind uce d f~bro~apillomas In cattle (Baker and
Howley, i9~7; : . Engel I<1 ~ 1983; He ilman <1 aI" 1982;
Natabayas~i ' <1' 'IL 1983) , Viral genes involved In <ell
transfonnati~n and plasmid , replication have bien . mapped to a
BPV 1 .fragment ., en~n:i~g. ~9 % ' Of\ the viral genome. This '
early or E', region of . , lJpy ' 1 contains eight ORFs, namely El . 10
'Es ' (Dli.n; s," ~ : w,', 1983)" The . remaining 31 %, ~ (the viral
genome, refe rred . to ' as the late region., contain' two large!
~Fs, Ll and , 'U, which ~~o~e
~ . . '
polypeptides ,of , the virions ' (Orth
for the m,or s t ruc~ur~ 1
and Favre, ' ' 198'5; Pilacinski
genitals (eg. HP~ ~ , 11 " , 16, and ' 18), skin (eg. cottontail ~bbit
papillomavrrus ' (CRPYI 'ond, HPV 1 , and 8), and ' animal
' fibroblasts (eg. Dr y ' 1 and the deer paPillomavirus; " Cole and
"..' Danos ; 1981), 'No gross ' differ ence,s in \the ,' ,overa~l g~nome
}~': : ' o '.gan iza tloo : .were, obs erved amo ng i he , ge nlt a l H PV••
~" . .Comparison, of the <genome ' organit.ation (see , F~gure I) , of ' HPV
'~"'~' :'1=':': -- .. ·-" = ,~ ::jJ
. prot ein coding seq uences)" I for -each :c;ad~g frame, '
are r~preshnted by ~pen b:e~ The~ ORFs· were identified
by comparing HPV 16, 18, ahd 11 sequences with other
!apillomavirus·. seqcenees ,(Cole \ ' and Danos, 1~87j . Dartmano · ' g ,
ill, 1986j ~edorf • .e.t .nL 1f &S)' The scale, in kilobases, is
'. indicated ' . by . marks 0 0 th~ Sieriome maps · allet the . total •len&!~ ..
(in base pairS) Is.shown on the ·right.. ;
, " '.f
and late (L)
j '
;.,.
,.seno~e" . '. ,The map
with the ' . noncodlng . region :
on -the left. ,~e ' early (E)
reading frames (ORFs; putative
[E::]
B"""1E5I'--:'L2----'1
o=J~ ,~,
I
"
[I
HPV18 ,
open reading trilmes
[!D ~ I LI
,....,~,11~, ---'1 " ,~
, ~ ,' /
KPV 11 ' .
open -reading fra~u
~ ~[2Q
EJ ~
~ ~ ,
\
I
" 19~ and HPV 11 . (Dartm~ t1 D1. ' 1986) reveals , that I the 81
ORF of HPV 16 ' is split .into two OIU:.s, each of which has
homology to po~t~ons . of ~ the El ORFs of . the other,
peplllomeviruses. This clone ' of HPV ' 16 was isolat~d from a
genomic library of - e an inva sive cervical carcinoma, thus
,6J,;> . . _
indicaji!!}. that this DNA may have been mutated before or
during its integration into the host"'chromosome(s) (Durst ~ g,
ill. 1983, 1~)" Analysis of HPV 16 DNA isolated from other
cervical . tumor . cells revealed an extra ' guanine at nucleotide
1138 indicating that in HPV 16 from most sources the' El ORF
in~ct (Baker g !!.l, 1987; Matsukura ~~m. .1986). This
suggests. thai the genome organiz<V:ion . of HPV 16 (Le. the El
ORF) is similar tq : the other human genital papillomaviruses. It
. would seem that differences in tissue "tropism, pathogenicity,
and "host range,' of these genital papillomaviruses may involve
~anges In their regulatory sequences or subtle alteration in
the .coding region sequences;
gene expression.
both of which may modify viral
/'
i.: Co~~1 regtons or Papillomaviruses
.""Ali ~f ' tbe ten' papillomavirus~ sequenced to date. have a '
single (from 454 bp for HPV 8 ,to 979 bp .for . HPV 1)
noncoding . region (ncr) extending between the stop codon of
. L1 ) and •the ' first ATG . codon of E6. ' At the i~te re~on ' end of
this ' ncncoding region . there . . is a purine + thymidine-rich
; ~'-" ..
. regi~n . (0 + Tcrich for BCni~~pillomavirU.Ses; : A .+ G-rich for
. kin p~~llo~aVi~USCS and " filr"ap8piJIomaVi;~'seS) of variable
.
length (Cole . and Danos, 1987). This segment ,contains, in - all
paptllcmaviruses, the ~olyad e nyia tion signal for ~ans~r ipts
.
.
the late genes (Baker and Howley, f
proximal 'segment of the noncoding)
repe ats or the papillomaVirus-sp~jfiCregion contains several
for the transcription of
1987). Th e early region
from the late region (Amtmann and Sauer, 1982; O\,ow ~ i!.L
19878; 1987b; Nasseri and Wettstein, 1~84). In BPV 1" this
region has been ' shown to harbor an origin of replication
referred to as the plasmid maintenance sequences or PMS·l
(Lusky and Botchan, 1984; waldeck -, J:t .w. '1984) and a promoter
'sc.quence (ACCQN4 CGGT ) po si tioned between (for gen ita l
papilloma virus e s) an d imm e dl a t ety upstre am (fo r all
papiUomavir uses) of the typical polymera se promoter elements
(TATA a nd C A AT -Iike box e s) . In hum an genit al
papillomaviruses the middle segment of the " ncr (upstream of
ACCGN4CGGT) contains '. a variable sequence of about 200' · bp _
long (Cole and Danos, 1987). Cole and Streck (1986) have
reported a 78 bp . duplication in this region of HPV 33. DU.~ .to
the size, position. and arrangement of thel 78 bp repeats in
the HPV ~3 genome, . these authors sfScst , that the repea~
may. function as" enhancers of viral gene expression. Indeed,"
enhance" activity' has been- iOealized to this region in several
human genital ' pepijlomaviruses -{Chew .c1 aL 1987c; Cripe ' ,cl i!l,
1987; Rando .c1 BL 19~: Swift .c1 aJ., 1987; Thierry and Yaniv,
1987: Thi er ry C1 iL 1987a). Immediately upstream of this
region is 1 0th er repeat of the . papi!lom ~virus .
sequenc e, ACCGN4CGGT: . these highly conserve d
enh ance r
specific
motifs are known to be involved . in the transcriptiOnal control"
of papillomaviruses (Haugen " n ilL 1981; ~jrochika l:.1 ID. }988;
Spalholz ~ il. 1987). Allhough the ear ly region p~oximal'
. portion of the ncnccdlng region is hi~ly conserved (eS~cially
among , genital paptllomavindes), homology ' tudies beve shown
that the ncr is one of the most ' variable regions even among
re la ted pa pillomaviruses. .' The possible ass ociati o n between
tissue tropism and these cis-acting~ula tOry elements (i.e: . '..,-;;
enhancers) will be dicussed in later sections.
I
I
.J 1.3 Papillomavirus prot~i~ runction
The SPV 1 transformed mouse C127 and NIH 3T3 ceils have
been useful in defining the functional organization of the viral-
' . "~
~ their protein products characterized (Androphy ~ 111 1985;
Burkhardt l:.1 ill. 1987; DiMaio C1 AI. 1986; Nakabayashi .l:.1 W.
1983; Sarver ~ aL 19847 Schiller C1 aI. 19~. 1986; Yang C1 aL
1985a): •Similar studies. h~ve indicated thai the El ORF of SPV
1 .~ essential for . plasmid . replication and m~intenance (LUsky
.' '.~'
identified and
and ~pl a smid
of .BPV I DNA.
tr ansformat ion
mapped' to· certain early ORFs
ce ll .
bun
instance.Fo r
functions have:replication
... separat e transforming genes, E5 and E6,
t
genome.
(')
. by iJ;l Y.ilm dissection and mutagenesis
( ..
s.
~... .
trans -activator tha t is involved in
indicat es that the role of the E2
maintenance and transformation is
the conditional enhancer el ement
<! l!l (1985)
E2 ORF
Rebscn ~ ~ .aL· 1986; · Sarver '-t i.I, 1984). Spalh61.z
. .
rccc~tly demonstra~ed that the full-Iength BPV
encodes a transcriptional
viral gene expression. This
gene product in ~id
indirect ; activation of
" 9
and Botchan, 1985, 1986). In ad~~n, the integrity of the E2 '
ORF ' was '!town to be required for stable plasmid maintenance
and, Ior efficient tra nsformation (Lusky and Botchan, 1985;-
(ACCGN4CGGT) leads to increased expression of critical viral
replication and lransft;umation' genes (Rab;on ' ,g .Ill, 1986; Yang
£t B1 1985b). Interestingly, the ' carboxytermina l portion of the
E2 'ORF product has been shown to possess a repressor
function (Lambert
exp ressin-g the
.c1 m. 1987; Cripe: -'.l i!l. 1987). A plasmid
putative ' rep ressor~ region inhibits cel lular
~. .
transformation .by BPV 1 DNA (La'mbert ~ DJ. ~987). The
authoI1suggest that", this inhibition results from E2 repressor
mediated - down-r~ulation of vira l ' gene exp ression . No
identifiable function has been assigned to the E3, E4 or E8
QRFs using ' this ,in Y.i1r.g transfonnation system (Nea~ ~ B1
1987 { S<:hiller-<! lll. 1986). " \.
Sim ilarities between paptl lomavtrus g~nome size and
organization have fostered the tendency to ascribe prope rties,
associated with a particular peplllomevtrus [i.e. BPV 1) • to all
--:irus es . In. som e situations t he hum a n and a nimal
p ap it lomevi r us O RF pro ducts seem to . share functional
homology. For ins la ned , r ece nt st udies jr ave
Irans(orming 'and trans-regulating funetlons :
the HPV 16 and )8 E6 and E2 ORFs (»ed eU n II. J 987; Cripe
~ ill. 1987; Mat!&Shewski g ill. 1987). · These functions arc
similar 10 those identified for the anaJagous SPV 1 encoded
proteins (Spa lholz " iL 1985, 1987; Yang ~ AI. 1985a) .
Alterna tively , the ES <?RF, a ll ho ugh im po rta n t fo r
Ira nsf orm ation by DPV I , is not homolog ou s to . the . -:~
....,.'
.......
corres ponding regions of other papilloma viruses except HPV
6b. Indeed. " some papillomaviruses do not have equivalclJt 10
the BPV 1 ES ORF and for those that do it is not known if
th e ES ORFs of , the se papillom aviru ses e ncode prote in
.prod.ucu . Regul ation pf gen~ expression in both human and
a nima l papilloma vlru ses a ppea rs to invo lve : differenti al
splieing, selec tion of ·one ' of the two p~lyadenylation sitC5,
an d/o r diffc;:renti a l sel ec·tion 'of t ~anscrip t ion a l star t sites
(promot ers). Preliminary studies suggest tha i this differentlal
mRN A tra nsc ri p ti on and proces s ing var y among .the se
p a pilloma vi ruses. Therefore, fu rl her RN A a nd prot ei n
characterization studies are required 1.0 fully understand the
life cycle of this medically important group of viruses.
1.4 Paplllomaviruses and disease; ·
Pap i110(llav!ruses have been identified in wans from meny : .
animal species. Animal papillomaviruses ind~ce three ryp~ .~f
. . :~
!
Lancaster and1985;(Green,
_.<
pl;Oliferating fibroblasts~~ntalnjng
~'Which contain in .addition
to epith elial-derived cell~, flbrcus connective tlesue; and (3)
fibromas; which' consist mainly of fibrous .connectj~e tissue
are ' beni~ tumors derived
Olson, ~ 1982) . Three animal papillomaviruses have been· shown&-
t~ be oncogenic in their natural host. These include the above
mentioned cottontail ra bb it papillamavirus along with th e
bovine papillomavirus type 14 (BPV 4) and the multimammate
mouse papillomavirus (MoPV). The cott ont ail r.abbit (Sh ope)
papillomavirus (CRPV). was the· first oncogenic DNA virus to
be' isolated and charact~rized (Shape and Hurst, 1933). ~hope's
subsequent investigations provided a new and " fascinating model
. of a' naturally occurring vifus-induced . neoplasm (Shope, 1935)
in which tumors either persis.t~d as benign papilloma s,
"r,egressed _completely , progtessed to . met ayasizing .
cqrcinomas (see .Kreider ,g ,ilL 1980). Kidd and ."Rous (1940)
also ' provided evidence for the ' development " of carcinom as .
under natural ' conditions in cottoi1tail rabbits. In', 1978, . Jarrett :
.~d .his colleagues reported the development, of BPV a-induced
aUm,entaJ}' . tract and . urinary bladd er in cattle . In
addition, Muller and Gissmann (1978) I reported . tbat MnPV. a
papillomavirus . endemic in the multimammmate mous e is
associated with skin tumo; formation.
Few ', papillomaviruse~ . can cross the· r host : barrier. However,
seve!~l ' paplllomaviruses ~re ', capable of ind~cini fibroblastic
tumors ' in hamsters and , of transforming ' the rodent .tissue .
culture cell lines 'e127 and NIH 31'3. This • subgroup . includes
the bovine papiUomaviruses BPV 1 and BPV._ 2, the sheep . <.
papillcmavirus, and the deer papillomavirus.
About SO types of human papillcmaviruses (HPV,) have been . ~
"
molecular ly cloned from epithelial lesions. A new type '.j
defined as a virus isolate exhibiting less than 50 % DNA
~omology with known HPV types, as determined by ..I?NA-DNA
hybrid iza tion und er stri nge nt conditions itt 1 iquid phas e
(Coggin and zur Hausen, 1979). Also, ~or many ofJ these types
a specific pattern of .. macroscopic and microscopic lesions has
been established.
All hum an pap illo mavir uses. . descri bed t o da te .Induce
epithelia l proliferations or ..~~rts. The clinical ,-significance of .
warts is dete rmined mostly by their location," the infecting
virus type, . and by factors "relating to the host. A ' wait on the
skin is most often benign self-limiting tum or whic h
regresses after a period of lime. Warts may ' occur at any
location on the. s~in, but cert ain sites are favored. warts
morphology . is also variable. Although the correlation ~ between
wart morp hology and infecting virus type is no t clear,
preferential a~socia tion l.of HPV 1 with deep plan tar war~s"
HPV . 2 with common warts, and HPY 3 with flat skin warts
. has been demonstrated (Pfister .t1 aL.198O; Shah, 1985).
It . ts genesally believed that infeciion with of the
virus typ es, in combination . with host and -envil'onmen tal
.: facton " ~ bad to ' nuill~q.. ; Presence ' of ' ~V DNA, 'RNA, '
andior " prot~in .' in . ~~'" : lc.sio.n;- h;., ' lead .~ . the belief' that
there Is a correlation between ' papiIJo~avirus infec tio. and
mal,ignant . cereino mes. ' One . such clinical conditiQD is Ihe
familial .skin disorder epide~plasia verru ciforn'tis (BY). . EV
is ' a genetic' disease characterized ' by disseminated, persistent
'skin warts , !1Jising during childhood and "by a high risk for
developing skin cancer -later in life. The development of skin
warts into cancerous . lesions is known to requir e sunlight
(ultraviolet ligl:tt) as a cofactor. HPV types 5 and 8 and' rarely
other ' types ...have been reported to be assoclated ' with this
', squamous . carcinoma , of th e . .~ skin, al thou gh patients with BV
commonly reve al infections' It with up to 15 additional types at
papill~Wuses /Kre;';"';,i ~ aJ. 1982,. · 1983; Orth <l . aJ. ' 1979,
1980; ;Ostrow , 1. Bl. 1982; ·~fer ~ aL 1981,1983; Yutsudo ";t
Il1. 1985). Ceneers arising from this _' 'condition · represent t o :
interesti ng example of , interactions between a ip ecific virus
infection' and physical c8.rcino~ens such ultraviolet light
(reviewed by zur Hausen, 1987).
. \
HPV antigens and/or HPV DNA have been demonstrated in a
high proportion ' of benig n (condyloma s) , prem align ant ' · and ,
. malignant tumor ; of the cervix, This ' , suggests that these
viruses may playa ' pIVOtal role in the pathogenesis of cervical
neoplasia (Boshart .d .11 1984; Durst .e.t W. 19~3; Gissmanri , -'t
W. 1983; , Lancaste r .c.t\ Al,' 1983):
shown that specific HI'V types ,
SUbseq~~nt1y, it has been
essocieted with benign
. ~
.j
present extrachromosomally, whereas , inami 11 DNAs
carcinomas, .. HPV 1(1 and 18 DNA are frequentl y found
covalently associated with tbe , host cellular· DNA. :rh,iS suggests
tbat viral DNA has been integIllt~d .. . ~to ' host . ·DNA. HPV 16
and 18 . DNAs have been found integratfd into the ' chro~osomat
D~A from sever~} "cervical . cell . lines ' (BOShart ~ W. 1984;
Pater and Pater, '1985: _Schwarz ~ , w. '," 1985; ,Yec ~D1 :' 198.5).
Integration may. be one of the ' steps on the road to.
is supported ,by observations tbat HPV DNA
intO invasive lesions.
• $fudies of cells that , ca~ the HPV DNA are · . revealing bow
the virrises "may . cont ribu t,~ to ' c ancer development . . _ The
physica l stat e of HPV DNA in : genital lesions has been
exa~rned by t Southern blot hyridization.\ iIi "co~mas" HP-V" 6
type may be an impottimt factor in
; types 16 and 18 are 'present . in ' 70 to ,80 % of .invasfve
squamous cancers of the cervb, vulva, end penis arid , . in the
. ' . 'higher grades of cervical intr aepithelial neopl asias (qN 3;
Boshart k1 n1 ~9B1; Durst C1 ilL 1983; ~ater l:1 Wo' 1986). In
contrast, HPV types 6 and 11 _are more often associated with
benign genital warts (Gissmann _ ~ .a1 ,1983) and also t('lh
laryngeal (Gissmann C1 i!1 1982, 1983) and nasal inver ' g
• _ OIl ' . ' 1 .
papillom~ (Resplee C1 ill. 1987). The .condylomas usually r main
static ~ or regress whereas the higher grade .' CIN lesions
virtually never regre ss and a certain' proportion will evolve
,
. to occur at random sites in the Mst
genome, .However, in the ' 'cervical cell lines HeLa and _C4-I,
papiUomavirus DNA is integrated in regions of the. hpmen
genome that are near the cellular protooncogene c-myc (Durst
. . .
~ ilL. 1987a). In both of these cell lines, c-myc expression is
J "">= elevatei relative'" to that in SiHa' and SW756 cells, which do
~ot . exhibit integration of papillomavirus DNA in the vacinity
of 'c-myt?- · Furthermore, Integration of . the HP.V enhancer into
host chromosomes. ' has the ability to alter the expression of
, ."the adjacent cellular ~ene pap- I '(Swift ~ ' .l!L 1987),' The
relat ionship of this elevat~d gene expression . and progression
, .
of HPV-associated genital. tumors to malignancy is unclear.
Examination of
l
papi!lomavirus D~A integration pattc!Ds , has
consIstently. shown . ; disruption ' . o~ the e~rlY region the reby
j?ining thr-~ORFs ~ E7, and ' El to ,.d~wnstream host ~11
s~quences(Schwaf3 .e1 .il.
~ , .!ranscripts have been de'tt:eted
1985). HPV 16 and 18 RNA
in both tumors and ' tumor' cell
'r , lmes, (Baker. 11 B1, 1987; Schneiner-Gadicke 'and Schwarz, 1986:
Schwarz .~ f ll1. 1985; Smotkin' and Wettstein, 198;6: Ye e ~ ill,
1985). Scbneider-Gadlcke and Schwarz (1986) have report ed
that 'mqst or Ieven all of the ' HPV IS-positive mRNAs
transcribed in " . H P V lS.con~a.inlng carcinoma cells are \
spliced hybrid transcripts that are composed of
and/or El) andsequences
sequences. The 3'~terminal ' host sequences are
different for each cell line. This suggests that these particular
host sequences may not 'play a role in tumorigenesisj :-, instead
. . ~ .
their role , may be to stabilize the mRNAs coding for the ~rly
region viQI! proteins. ~ese viral proteins may be' required for
• the. ~aintenance of the malignant phenotype. For HPY 16 and
18, splicing generates e " new ORF, designated E6- (Schneider-
Gadi.cke and! Schwarz, 1986; Smotkin and Wettstein, 1986); HPV
6 , and 11, however, do not contain the require~" splice donor _ .
and a~ceptor sites (Schneider-Gadicke and Schwarz, 1986). \
HPV 18 E6- polypeptides have been detected in HeLa cell\
extracts by monoclonal antib6dies (Sneider-Gadicke, Kaul,
Gaus~pohl, Schwarz, Frank, and Bastert, in -abstracu of papers '
presented at the Sixth International Pepillomavirus workshop,
' 1987). It would seem' that this protein may be at least
partially responsible fo r the differential pattern of .
pathogenicity observed 'by the : two genital papillomavirus
grou~ (HPV 6/11 versus -HPY 16/18).
Interestingly, the E7 gene product is the most abundant
protein in cell lines containing HPV 16 and 18 DNA (Seedorf
' .'1 . 1\1" 1987;Smotkin .and Wettstein, 1986). Also reported ' by
Seedorf .e..t al (1987) was the presence of the E6 and "E4 .gene
products -in HPV 16-conl.liining cells and the presence ' of· the ,
El.en'coded gene product in HPV ~8-containing · cells. The E7
Pf9tein. of BPV I I , is "involved in the maintenance of plasmids
''l
":'0"
..
poorly conserved
all of
main tenance of transform atione-,
, " ,-:
the BPV 1 carbOi>'!-ermin9.1 E1
for . e~iso~al ' ,replica tion " In transformedproduct required
mOuse cells (Lusky and . Bctcbea, 1985, 1986); the BPV' 1 amlno
requi rC?d, "for ' ini tiatio n
The E6 .and . E7 protein sequences
among papillomaviruses. This may' a~oun~ for
transformation.
However, the . localization of the transforming function of mv
16 and 18 to proteins from the E6/E7 region of the integrated.
papillomavirus genome (Bedell J:1 ill. 1987; !"1atlashewsld J:1 i!l.
1987), .d~ i~dicate a role of the HPV E6 and E7 proteins'~
the observed variability in tlle oncogenic potential of the
~Vs. However, the ·E6/E7 gene products do contain regula~
spaced (Cys·X·X ·Cys) cyste ine .doublets, similar to repeated
units described in a number of eu'karyotic nucleic aeier binding
proteins (Berg J:1 D1 1986). Thus an attractive possibility ' is
that the E6 and I{Z ORFs encod: nucleic acid' ~i~ding proteins.
Specific bindi ng . of the E6/E1 ORF gene products to
. terminal El . ORF e~cs a' factor which acts as- a modulator
of . vital __D~~ -replic8.~on (Lusky and Botchan, 1986; Roberts
and Weintraub, 1986). Some of these viral proteins may not be
chromosomal DNA may, be a mechanism br which HPV
mediated : tra nsformaiion' occurs . Und erstanding tbe regulation
01 viral gene expression and the regulatory roles played by
these viral proteins may shed light tbe mol ecul ar
mechanisms of carcino~_~nesis by these viruses.
<"': / '
· 1.5 TraDscrlptionaI regub.t10Ji, 01 gene expreul OD,
Defining tr an.script ional reguJ8:to ry signa ls represent s
import ant step toward our understanding' of eukaryotic gene
e xpress ion. The tran scriptional regulatory signa ls generally
include (1) pr om ot ers, en ha ncers , and negativ e reg ulat ory
elements at the DNA level, and (2) trans-acting factors which
interact with these DNA sequences to produce a negative and
positive effect. A· promoter is genera lly comprised of cis-
actin g seq uences like the Ooldb~rgIHogness or . TATA box
(TATAArA) and one or \lore upstream promoter : element (UPE)
such 'as th~ CAAT box (OOCrCAATCI) the OC box
'(GGGCGG). Th~ " TATA bcx-c-a nd the UPEs are ' generally
required for. accura te and . efficient initiation or . tra nscription
(Sassone-Corsi and Borrelli, 1986).
Enhancers w~ie original1; identified in the DNA tumor virus
SV40 (Ban~' ~ i!l. 1981; M~reau ~ Dl. 1981). These cis-
ac ting DNA elemen ts
~
eith er , , homo logo us
dramatically stimulate transcriptjon Jrm
or .the t e r ologous p ro mote rs in a n
or ienta tio n-i nde pe nde nt ma nne r (rev iewed by Sa ssone- Corsi
a nd Borrelli, 1986; Serf ling C! a.L ' 1985a ). . However, the
distinction _ between enhancers and UPEs is not always ' clear-
cut With 'examples of each type beha~g ' interchangeably. . For
exa mple , th e 'immediate' upstream reg ion of th e
,metallothionein gene which, when detached. from its TATA box
and linked' to 'a test gene, can act induc:iI?le enhancer
promoter is ' referred to
Negettve ~egu latory "elements (or s ilc~cers) " are cis-acting
DNA sequences identifie d upstream of several cellular · and
Viral genes (Brand .c.1 .aL 1~8S j Gorman ~ A1. 1985; Nelson .-"
aL 1987; Rosen ~ W. 1985). Although not fully characterized,
some of these negative regulatory elements have been reported
to repress gene expression in an ' orientation- and distance- >
,.
independent manner (Baniahmad ~ .aL 1987j Laimins k1 , ill.,...
1986; Remmers~ JlI. 1986).
\ .
AIfhough- enhancers were ~dentified seven years ago (Banerji
ilL 1981), .. t he mec banisn;J .flY whic h they a.l!tivate
transcription is. ~till unclear• . There '( isJ no extensive homology,
' amo~g these elements, however 8 number of' short individual
sequence ' motifs 'or " core sequences ,have been i.dentified (a~d
often repeated) in a number of enhancers. A plausible belief is
tha t ' the interaction of cellular trans-acting protein factors
with the core sequences is 'central to enhancer function. In
fact, several lines o'f evi~en~e indicate such pro teinlDNA
inter action. In. ~ competition experiments performed with '
the - SV40 enhancer, r~vealed Iha~ ' increaslng amounts., of the
SV40f: enhan~r '.(pSY2-'NEO; SV40' enhancer linked i~ the~~ '
gene) decreased t~anscription from p~V2-CAT (SV40 enhancer ..
linked, 10 ·the . chloramp henicol' acctyltransferase [CAT] gene)
indicating the pres~nce Of " a limiting (..amount ~f positive trans-
gene expression (Gorman .e..t a1 1~85). In ' addition; in ~
protection a~
of neg ativ e
cells which binds
negatively regulates
presence
DNasel footprin'ting, gel retard ation,
. .
in undifferentiated Ee
(SV40 ' and MSV). and
indic at ed
dimethyl . sulfa te pro tection, and. exonuclease
exp erim en ts such
experi~ents have
regulat ory ~ factor(s)
. .....
to viral enha ncers
acting(f'~rs (Me"';la <I : &201985:. Sassone-Corsi
Scholer arid Gruss, 1984; Wildeman ~
pro mote r h..
sug gest s th at
formati on of
sequences from
have provided evidence for such interactions. Further results
from competition experiments sugges} t~t the SV40enhancer
(comprised of many core sequences) and factors that bind to·
it, to be involved in the establishment of sta ble '
i:ranscripli on al compl exes ·- (Wa ng and Cal am e, 1986). A
requirement of stereosp ecific alignmen ts between the enhancer,
UfEs and the TATA box for initiation from the SV40 early
bee n shown (Ta kahashi ~ !l. 1986). This
init iat ion of · tr an scription may requir e th e
prote in/prote in interactions -i nvolving the DNA
the enhancer ... and promoter region (see below).
Mark Preshne, in an ' excellent review based on his work, .
attempted 10 ' . explai~ several models put forth to elucidate the \ '
mechanism of enhan cer function in tr anscri ptional regulation .
\ "-..J In one such mod;1 (looping) Ptashne maintains that protei~"
bound , a.t widely separated sites . act to , ~gulate transcription .
by . contacting • one another, ' with the Intervening DN"A ' looping
b~nding to mlow the proteinlprote~n interaction: Ir" looping ,
proves . : to bel)a general phenotpenon . (discussed mainly '
repressor binding), Positive· and negative control might oc~ur
by 'proteins ,binding to < the complex or loop, thereby increasing
or de~reasing ' the CffiCie~cy of potryerase n interaction with j
the promoter JPtashne, 1986). .
The SV40 enhancer has been shown to act ' in a wid\.. variety
of tissues ~d hosts. Many other viral ~d cellular e'Mancers
show stric't host anlf'" cell -type sp ecificity_ The
immunoglobulin heavy chain (IgH) enhancer was the flrst ,
genetic element identified to be expressed in a tissue spe~ific
manner (Banerji ~ Bl. 1983; Gilles ~ ill. 1983). Tissue-specific
expression of cellular genes has been proposed to result from
interactions betwe en cell-sp~ci~ic trans-acting factors with the
factor which binds to the octamer motif of the immunoglobulin
heavy chain gene enhancer, has been implicated in the tissue-
specific regulation of immunoglobulin genes (Rosales S!1 ilL
1987). Other . studies suggest thai immu~oglobulin promoter and
B cell-specific protein
also cap able of mediating cell-
enhancer elements. For instance,
intrag~nic sequences
specific expression, independen~ of enhancer sequences
(Calame, 1985; Foster ~ ilL 1985; Grosschedl and Baltimore,
1985). In fact, a sequence identical to the enhancer .. octamer
sequence (ATGCAA1) is found upstream of the RNA start site
of the immunog1~bulin heaVy and light chain genes. Earlier
reports id.tified more species . of factors that recognize these
octamer motifs. One factor is present in all cells whereas the
other has been found only in ·Band T lymphocytes ~dolf'
ilL 1986; Staudt 01 1I1 1986).. Inte..,tingly, lmJ~r 01, ' lt1 (1~
have. ....shown " t hat tis sue-specific e xp ressio n of t he
immunoglobulin gene is at least in part controlled by negative
regulation in nonlympboid cells. The situation observed for the
regu lation of im munoglobulin cell -specifi c expression suppor ts
\,
the modular mechanism of tissue-specific gene expression, In'
th is model, general and/or cell specific factors interact with
ubiquitous core sequences or ceII-~pecific motiCs and in effect
positively negatively regulat e gene expression leading. ·to.
tissue-specific tran.scription (reviewed ; by Voss' Stl . ilL·. 1986).
The cell-specific factors\ mentioned above may be contlned to
cells of a specific tissue or developmental stage, Alternatively,
as observed with' the kappa chain gene enhancer, these , factors
~ be present in many cell types in ~ inactive Iorin and
have to be modified in some way (e.g. phosphorylation) before <
they bind specific a lly to ' the tissue -specifi c enhancer
(reviewed by Dynan, 1987;' Mania~.is '-l Il1 1987).
"
1,6 Statement on the research problem
\
of malignancy .
, .,.: f .:> -. :. :>.- ,,1...: ~ ,. :.-.',-"
developmenttheviruses. infor ' theserol e
Human papillomavirus types .16 and 18 are associated with
the majority (70 to 80 %) of ' tumor and tumor cells of the
cervix , whe reas HPV 11 is associat~d predominantly "with
I ~ benign anog enita l warts. This strongly. suggests differenti~l
However. because of the , lack of a tissue culture systeID: ' th'at
the replicatloncan support
~derstood ' how the
of the
genomes pf •these
HPVs~
viruses
it js not well
arc ·expressed or
regulated . 'It is, however, important. to study the , gene
regulation Of HPVs that are associated with carcinomas of the
cervix in ' order to increase our understanding of the molecular
mechanisms of carcinogenesis by these viruses ,
This investigation of HPV 16, 18, and 11 transcriptional
regula.tion was possible due to tile availa,bility ·.of the pSY-
CAT (the bacterial : chloramph~nicol acetyltransferase gene
driven ' by the- ' SY40 earfy promoter~ expression vector system
(Gonren g ' B.l, 1982). This technology provided a quick" and
simple assay . of enhancer and promoter function: Transfection
' ~f the
derived
HPV noneoding region/CAT
! ' .
Crom cervical carcinoma cells
Flasmids into
(i.e., c33A,
cell
HeLa,
lines
and
SiHa) B,enerated in ri1r.2. system capabl e of provid ing
valuable information on HPV gene regulation.
. .
The .objectives of this investigation were: .
1. TQ initiate ~ comparative study of and to characterize the
and promot~r function
,
sequences necessary for enhancet
HPV 16, is, nnd n.
2. To determine whether HPV enhanceri and/or promoters
cl '
. expressed in a cell-specific manner.
3. ' To ' further characterize the regulatory function essociated
, \
. with the ' early gene products of HPV 16 by ' studying how
gene products regulate . the enhancers and · promoters of
.>
HPV 16, IS. Ind 1J. -
-,
,.
'\ '. -.; ...,.: - •• • ~• .' ~ ,... ..,..,...:. ··-..... ~ ..:.1::' ..~_<' .:::·f'.: .. ... ..
I
. _.' . .; " ~
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2.1 Materials
MATERALS AND MImIODS
Restriction endonucleases obta ined " from New England
Biolabs, Bethe sda Resea rch Laboratories CBRL) or Boehringer
Mannheim. T4 DNA
intestinal phosphat ase
transcriptase from Life
Ligase was purchased from B~L, Calf
(CP) from Boehringer-Mannheimj reverse
Sciences, and 51 ' nuclease froll). SRI-
The radioactive (14q . cbjoremph eraccl was purch~ed flam Ou
Pont while the acetyl coenzyme A, lithium . ~as obtained ~ ' f~
PharI98cia P·L Biochemic als. ,F low Lab or atories supplied the
tissue cult ur e medium (Dufbecco's Modified Med ia; ~ DME) .
penic illin-strep tomycin (Pen-Strep), phosph ate buffered saline
(PBS) and ' the trypsin-EOTA, while Bocknek Labor atorte s
supplied the fetal bovine serum (PBS). The T4 ligase 5x ' premix
,~. ' .
and . of the restriction endonucle~e. (lOx REact) buffers
were obtained (rom BRL. The re maining restriction enzyme
buffers and the , reverse transcr!ptase premix ...made
according to the- recipe (rom ' the company. ' Th.e -.JJ~ 'lOx
made ac~or4!.~K._ to Maniatis -(198Z). The l Ox 5J
premix contained 50 roM NaOAc (pH 4.5), 150 mM
3 mM ZnOZ (Hiros'hi Hamada, personal I communication),
..
26
. : . The " p~asmids -. pSV2.cAT,pSVo:<:A.T. and pAIO-CAT were ' kindly
provided by B. Howard while the HP~ · 11, 16. Bnd 18 pJasmids
wert obtain ed fro m 1.. Gissmann and H.. ZUf Ha use;"
U RteOmbillBDt vectors
Plasmid pSV2-CAT (Gorman ~ ID.. 1982; Figure 2), containing
, .'
5.\'40 regulat o ry se quences (pro moter ' and ' e nhancer) which
control the e xpression of the linked bacter ial ' chloramphen icol
acetyltransferase (CAT] gene, was used as the positive control.
The negative controls , were . pSVo-CAT and pAlO-CAt; these .
'plasmids are ' the yccton from which all HPV/CAT ' constru cts
w~re derived. The' pSVD-CAT plasmid is~rived from pSV2-
CAT bY" the removal . of the 'entire .~ncer and promoter
. "gK>n'" (th< r Pvul llHmdlll fragment of pSV2-CAT. Figure 2)' of
SV40 ::~Gorman . " ilL . 1982); - wherees, pAIO-CAT' is missing the
SV40 .enh~ncer 'sequences but reta ins the SV40 prom oter
• ~i
·. r
..~
.·-1
:-:
(Figure
repeated
2). Th e
sequences
plasmid. pAlO-CAT , containing the
and Goktbe rg-Hogness box coupled 10
21·b p .
CAT
was gen erated b)' joining the SphllBamH (CAT. conta ining)
fr~gment of a pBR322 deriv"ative plasmid \vith the SphI /BamHi
/ fra~ent 0(' pSV2·CAT (Laimins ~ .uL 1982). The .sphi site
was not regen erated, therefore a BglII linker was inserted .~n .
this site for cloning purposes (Figure 2). The CAT gene in
pA10:-CAT will be active only if the inserted HPV DNA
fragment conta ins an enh•• • '" ( clement since the SV40
.~..
: ...• ,..
map or the
P~o.CA'r, and 'pAI0f4T. '
pSV2-e-AT cantatns the ~Iowing functional clements
(Counterclockwise from 12 o'clock on the .ciic~ar map): the
AmpR' ' ~istron. the "Origin of replicati'on from pBR322, the
SV4"O early promoter region, the chloramphenicol
acctyltransfeiase (CAT) . gen' sequences. the SV40. small
antigen Intron , and the SV40. early region polyadenylation
addition site. -The SV40 regulatory region (Pvull/HindlII)
indicated . as two boxes representing t~e 21 bp repeats and
two ·larger boxes representing' the 7~ . bp . refCats, while the
d?~nstream .SV40 sequences are "<represented by a , double
line, . ' '1]I'e plasmid, ,pSVo-CAT was constructed by d~ leting the .
SV40 early . region (the PvuIlIHilidIIl ' fragment) frpm pSV2-
CAT and religating the plasmid after the addition of HindllI
linkers (G?~man ~ il. 1982), The plasmid pAlO-CAT,
, carrying the 21 ' bp repeat ed sequences was generated by
joining the Sphl/BamHI fragment from ~ pBR322 derivative
. plasmi,d with the SphIIBamHl, fragment from pSV2-CAT. ~fter
the addition of B&!I1 linkers (Lalmins '-1 iL. 1982).
·.""
•
..>.
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promoter is enhancer dependen t. Fo~ ' ' am- yin! HPV # p~mo~er
". . activi.ty, - the . HPV.pSVO-CAT plasmi~s ' in reve rse ' or ienta tion
"background in some een lines. This . high background, which
. . .
has ' else been observed by others., is probab'1y d ue to cryptic
promo":r activity from pB.~22 sequences.
were used negative .~ntrol~ ' since pSVG-CAT ' gave bigh
i~- \. 1.3 HP~ nODcodlDC ngio; constructs
j -
To analyze the pote ntial t ranscrlpnonal enhancer elements
contained . within the non coding region (ncr}" of HPV 16, 18
and '11. a large fragment corresponding to . the ncr of each
virus " was .cloned . into the plasmid pAio-cATo · This ~(or . has ·
s single Bglii site for insertion of · ·fragments . to test for
enhancer . activity . (Figure 2). .To screen for' _ the papillomavirus
promoter (a long ~· wi tb the. e n ban~er) sequences, the ncr
fragments also cloned into _ pSVQ.CAT, which contains aO •
~ i n g le Hin d III site fo r inser t io rf of putal ive . p rom oter
fragments. Th e· HPV 16, 18, and 11 ncr fragment
. ~para(ed from the viral codmg region and pBR322 , DNA by
"y. cleavage with ' an appro pnate restrictio n end onuclease fOI;~ed
::;. by. reverse tre bscrtptase o r 51 nUcl~e treatm~nt. " The " reverse
transcriptase enzyme was used · 10 ml in the lermini of DNA.
frasments with pr o truding '5' ends. Cleavag e by parti cular
re striction enzymes (i.d. Pstl) created recessed 3' ends; . SI
used . in these instances 10 . re move Ihe single ' .
I
J
.,
"J",
Next, the blunt-ended fragmen ts were · ' subjected toends.
stran d tails
eleetrophoresls together with a marter for size .- ~termination.
The appropria;t~ :.' size fragments ' v.;:re ea:cised from the aProse
(o r pol yacry1a mide) ge ls and 'subse quent ly isolated by
etectroeluti~n. The eleetroeluted DNA was · applied onto DE52
columns, washed , with I x TE (fris-ED"rA), eluted by .5. M
'. ,
NaCI, and · recovered by ethanol precipitation. Vectors
prepared for ligalion of the inserts as follows: plasmid vectors
pAlO-CAT "and pSVO-CAT were digested with ' BgllI and HindII ~, '
r espe c ti ve ly, tr eat e d: with re verse .t r a n scri p ras e " _a nd
ssubsequenuy with calf intestinal ph osph atase (eIP). elP '
treatment was · required ' to remove the ~ terminal S' phosphates
from . the ' ends of the vector DNA such that the level of self-
ligation is diminished. Ligation of the vectors and inserts was,'
~ most cases, ~rformed in ! IS PoL reaction overnight at 16
C. The ligated DNA then transfeeted into bacterial- HBIOI
\
competent cells and plated Ampicillin 1.8 plates ' (Maniatis
~ .Ill:: 1982). The desiri=d recombinant clone was ' .selected by
using a raoditlcation of the Bimboim and Daly (1979) method
for small scale DNA ' prepa ration. Screening was. accom~
by restr iction endonu clease digestion of this plasmid DN.A
fo llowed 'by analy sis agarose a cryla mtde ge!s.
Recombinant plaJmids were' pr92agated in HB101 cells using" M9
. minimal media. Afler overnight a~plification . in the 'presence ,;~
~ : .
Pog of chloramphenicol per mL, -. plasmid DNA was
i:·
': • . ' . : , ", I:;' . ' ~" -.;~ ..... , ; , • .;••.• '.';' ,.~ .\
using lhe lys~ by a~ technique and purified -by .
cen trifisa lion to equilib rium . In cesium chlor tde-etbtdium
b"romide density gradients. These la rge scale plasmid ,
preparation procedures ar.c outlined in Maniatis ~. ill (1982).
.Tc screen . for papiltomavi rus enhancer and promoter
elements, large fragments containing . the noncoding regions· of
HPV 16, 18, and 11 (Figure 3) were inserted into the CAT,
vectors, pAlO-CAT. and pSVo-CAT. The BamHI fragment (6929 ,
to 119; Cole- and Danos, 1987) .of the HPV 18 · noncoding r~giotl
was . si nuclease ireated and inserted into the BgllI site of
. pAlO -CAT . resulting in t he construc ts p8 (+; positive
orientation . relative .'to CAT) and p9 (-; negative orientation
relative -to CAT) and into tbet HindIII sit~ of pSVO:CAT to
gen~Jte p29- .( + ) an~ pT·13 H. The HPV 11 ncrlCAT plasmids
cons tru c ted by inse rting the 51 nuclease treated
~IIIf.ifaNI fragment (7486 to it4; Dartmann ~ ID. 1986) into
pAlO-CAT to generate p6 (+) and p5 (-) .an~ into pSVO-eAT to
generate p2"' (+) and p14 (-). The HPY 16 Ba~HIIAvaII
fragment (6150 to 112; Seedorf ~ .al; 1985) w~s trea ted With
reverse tranacrtptese and ligated into MIO-CAT to produce ,
plasmids · p7 (+) and pa ' (-) and into pSVG-CAT to give piS (+)
. and pI 7 H. The HPV-ncr-CAT constructs are ' outlined fn
~;gure 9 (p 56).
; .
BamHI; Bb. B~I; as, BssHII; D, DraIII; Hp, HphI; N, NdeI;
R, Rsal; S, Saul; Sf. SfaNI; Sp, SphI; Ss, Sspl. The numbers
, The ' diagram present s a linear restriction map of the
noncoding region and surrou nding _L1 and E6 open reading
frames, The ' restriction enzymes are: A. AceI; Av, AvaIl; B.
Figure · 3. Reltrlctloa eadoDucieale
reglODS or HPV 16, 18, aDd It.
•
represent . recognitionI
restr ict ion enzymesvarious
bottom
Q
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sites (base pairs ) for the
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2.4 HPV enhancer conltructs ~
The. flAIO-CAT vector was wed to I te the small~st HPV _
DNA fragment with enhan~r activity. ~e V 18 BamHI
fragm en t was dig est ed with Acci at }nucleotide 7766 · to
generat e' two fragments (Bam H/AccI and AccIlBamH). The
BamHIIAcci (837 bp) fragmen t was isolat ed, blunt- ended by
reverse transcriptase and inserted into the BgllI site of pAl O-
CAT to give the \construcu pT-46 (~;Figurc 10, p 61) and p.T-4
(.). The ' HPV · 18 plasmid DNA was digested with SCaNt and .
Acel and treated with Sl nuclease; a 347 bp fl!lgtn~nt (74i9 to
7766) which contains an E2 bindin g domain sequen ce was
Isolated , and inserted into pAlO-CAT to givepT-ll . .(+;Figure 6,
p 42 and Figure 10; p 61) and pT-2 (-;Figure 6, p A2 ). The
BamH IIAccI fr agme nt rpent ion ed above digest ed to
p6 (+). Th~
diges ted with
digested with ,',
bp and 4183
followed by .'
digestion 10 rq':~
bp. The p6 .\ic';~
, :.~" ;."" ,,~; " ,~ "
comp let ion with Rsal to give four fragments. These blunt-
ended frag me nts inserted 'into pAlO-CAT, and the
ptasmids pT-81 (+) and pT-18 (.) containing the 230 bp RsaI
fragment (1508 to 1738) were isolated (Figure 10, p 61).
The HPV 11 , enhancer plasmid ~ derived from
D~aIII/SfaNI-pAla:.CAT plasmid (Figure 4)
Saul, filled. in by , reverse transcriptase and then
BamHI to generat e two fragment s with sizes 2001
bp. . Similarly, pAIQ..CJ\T digested with 8glII,
treatment with revertL- transcriptase and BamH I
give two fragments J with ;izes ' 1832 bp and 3799
The pl asmid pT.2S car rying th e HPV 11 I en h ance r
(repres ented by the thick solid line) upstre am of the SV40
' 21 bp repeats and Goldbe~ogneS5 box was generated by
join ing th e SauIlBamHI fra gment of p6 (the HPV 11
ncr/pAlO-CAT 'plasmid) with the BglII/B a mHf fr agment of
pAlO-CAT.
II '
' r
,; '; ' ..
1
1. Bgi II
2 . Rev . Tra ns.
3. BamHI
JBa~H I
~
. ~ate
1
'.Sau I
2 . Re v . ,Tra ns.
3 . Bam HI
0"RAmp .. • BamHI
. '"
BamH I
\
diges ted 10
. l~
0;. , '
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and pAlo:<:AT . derived fragments wete isolated
bp pAlo-CAT fragment (containing CAT icque nces) was ligated
10 the 4183 bp p6 fragment (containing pBR322 and mv 11
[OralIllS a ul) ' e nhancer sequence s) to "genuale the enha nce r
plasmid pT-2S (+). The 'pl:Smid pT·25 differs Irom p6 in t~at
the Saul to SfaNl fragment containing the promoter sequences
has been remov~d (Figure 4). Plasmid, pT.1S was digested to
completion with Ndel and the 4110 bp fragment" containing 213
bp (7657 to 7870) oC the ~V 11 ncr and most of the pA lO-
CAT scq uenets . was isolated and sell-ligated to generat e pT·1
(+; Figure 11, p 65).
The ~PV 16 8 am HIIAvall fragme nt
." ,.'
obtained by digcst j~g pT·SO with Sphl . and Sail. The rr8g~cnt
. containing HPV 16 DNA from 7463 to ms (315 bp) and mOSl
of pAlO-CAT was ' isolated ~nd se lf-ligated
Similarly, the pT-6? (+) construct was
upstream .sequences
to pro~~cc . pT:3.
completion with Hphl to give - three fregmems., The middle 1340 '
. bp fragment was 51 nuclease trea ted find i~scned into pAlO-
CAT to ' give the enhancer ~Jasmid pT·SO (+) (Figure 12; p 67).
}l, PJasmids pT-3 and pT-69 arc derivatives of pT.SO (Figure S).
. \ P!85mid pT·) (+) was obtained by subjecting pT-SO to partial
digestion ~th . Sspl since there are . two Sspl sites in the HP V
16 Hphl fragment (8t 6SSI and a t 7224) and many sites in
pAlo-cAT. The . DNA Wu then digested with Sail and flush-
ended by reverse transcrtptase. Th e fragment containing HPV
16 sequences - from 7224 to 7nS along with most of the
Sphl/Hp hI and the SspUHphl enhancer fragments of HPV 16,
\
5. Schemade diagram of J1PV
constructions.
(
HPV 16
removi ng
by thick
50. The
e nhancer subf ragmenu constr ucted by
upstream noncodlng region rrJgment (represen ted
solid lines) from the HPV . l~nhancer plasmid, pT.
resulting constructs, pT·69 and pT-3, contain the
respect ively, inserted in the 8g lII site of the enhancerless
plasmid pA ID-CAT.
\
3'
· '.L.,_" ._.
\
1 Ssp I partial
2 Sail
3 Rev. Trans .
4 Rellgate
. )
of pAlO-CAT blunt-ended by SI nuclease treatment and
self-ligated to gener ate pT-69. A , restriction enzyme map of
the noneading regions of HPV 16, IS. and 11 is given in . ~.;~
Figure 3 '(p 32).
2.5 Construction of plasmids to lest the effect of progressive
deletions on the enhancer activity of IIPV 18
The plasmid pT-39 (+) was constructed by insertion of the
BamHIIAvalI (6929 t.o 56) fragmen t (blunt-ended by
transcript ase) into the BglII site of pAlO-CAT. Similarly, the
BamHl/Bbvl (6929 to 7837) fragment was treated with reverse
transcri tase (re sulting in an endpoint at 7854) and Inserted
into p 10- AT to generate the plasmid pT-33 (+). ' Th e
positions of Av H and Bbvl in the noncading region of HPV
18 are shown in Figure 3 (p 32) and in Figure 16 (p 98).
2.6 Constructs containing the SV40 and HPV 18 enhancers
upstream of and downstream l'rom the CAT gene •
The 342 tip PvuIlIHindIII fragment of pSV2-CAT containing
the enhancer and pr~m_o~er of SV40 (Figure 2, ~ 27) was filled
in . by reverse transcriptase and ins;rted into the Xbal (blunt- .
ended by reverse tra nscriptese ) site of ' pAlO-CAT to give '--L
plasmids pT-SI (+; positive rel~e ' to the direction of CAT
. . ' ~ , .. ; i- :. ,,~..,.
41
tr anscription) and: pT-42 (. ;Figure 6) . Similarl y, the $1
nuclease treated. 347 bp SfaNJlAcel fragment of HPV 18
inse rted into the Xbal site of pA10-CAT to . generate pT-S3 (+ )
8':1d pT·52 (-;Figu!c . 6). Plasmids pT.ll (+ ) and pT·2 (.),
mentioned earlier, have this 347 bp fragment inserted into the
BglII site of pA to-CAT (Figure 6).
2.7 ~rudiOD of plasmlds to ana lyze sequences required
for promoter function of DPV 18
,
The HPV.ncr-p~VO.CAT plasmid, p29, was subjected to
partial BssHII diges!ion since there are twQ &s HU sites in lhe
i-rPv 18, BamHI ncr u,agment (at nucleotides 7572 and 108;
Figure 3, p .32). The DNA was then digested to completion
with Ndel generating ' (our fragments of sizes 694 bp, 1084 bp,
4460 bp and 4853 bp . The ends were modified by treatment
with transcriptase and the
sub sequently isolat ed and
largest fragment
J
se lf-liga ted ' to
(4853 bp)
give pT-29
(Figure 7). Plasmid pT-29 has both enhancer and promoter
~(7572 to 119) in the same orientation. Plasmid pT-4, which
. con~ns . a single BssJ:.llI sire at nucleotide 7572 (HPV DNA),
w.as ~ested to completion with this enzyme, blunt-ended with
reverse' tren scrlpt ase., and subsequently digested . with BamHI.
Similarly, p29 ' was digested with AccI, mied ' in by reverse
tr anscriptase, and then digested with BamHI. The resulting
.lragme,!~ of pT·4 and .. p29 were run separately on egerose
r
FI,UR 6. Stntqy ror coD.tnactloD or ' pla.mld .
tbe 'SV40 ' and .~ 18 enhaQ.ttn adJae:tDt to and distan t
from the SV40 promolt r.
The HPV 18 347 bp (SfaNUAccI) enhancer fragment was
inserted upstream and downstream -of the CAT ' gene t t the
BglII and Xbal s ites , res pec tively. Similarly the SV40
Pvull lH ind lll fra gme nt was ' removed from tbe pSV 2-CAT
plasmid and inserted downstream of the CAT gene. in the
X bat site (pT-42 a nd pT-51). The arrows ' · represent the
direction of the HPV 'and SV40 ~ncer fragments~ A, AccI;
Hi, Il!ndIII; Pv, Pvull ; Sf, SfaNI.
• I~
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Plasmid p29" is a HPV 18 ncrlpSVo-cAT . construct in which
the . ' HPV 18 enhancer and promoter arc represented by two .
thick 8JTOWS. The HPV 18 enhancer and promoter are in- the
' orientation as tbe coupled CAT .gene in p29 (BamHl ;
6929 to 119) end in pT-29 (BssH11JBamHl; ' 7572 . to 119). ·
However, the pT.28 and pT·37 const ructs have the HPV 18
"
e nha nce r ·(DssH/Accl ;
orie ~ tat<it\.r rel ati ve
7572
to th e
to 7766) in th e opposite
H PV pr om oter a nd SY4 0
'1~: .>:
promot er , respe ctively. Plasmid pT-4 has th e HP V 18
BamHI/Accl fragment (6929 ' to 119j inserted upstream of ' the
CAT gene (in the opposite orientation).
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geb. The pBR322 . DNA segment together .with HPV enhancer
sequences of 'pT-4 (3993 bp) and the
the HPV I pro mo te r sequences o f
electroeluted and ligated to gene~te
the same pT-4 fragment was ligated
to .... give pT· 31 (F igure 1). Th is '
produced ' from a BgIIJBamHI djgcsti~n
CAT DNA together with
p29 (18 44 bpl .
pT·28 (Figure 7). Abo,
to a pAlo.cAl:' fragment
pAlO-CAT .: fragment
with the BgJll ends (but
not the BamHI ends) fill ed jha by
• treatment.
transcr ipt ase
2.8 Construc tion or plasmid! expressing the HPV 16 .E2 and £7
gene products
Plas~id pD-1 (50 1 to 4334; Figure 14, p 82) contains intact
E1. El , E2, E4, " and E5 ORFs " (pD-2 contains only part of E1;
SOl to 700 are missing; Figure .14, p 82) driven by the SV40
early promoter and uses its own . polyadenylation signal These
plasmids were constructed by subjecting HPV 16 plasmid DNA
to part ial
completion
digestion with Hpall . The DNA waJ then digested to -"
with Saul. - ~ The HpaI lJSaul jB)3 bp (pD-7) and th:
transcriptase, and ' cloned into a pSV2-NEO derivative
(similar to pS\' 2-CAT shown in Figure 2, p 27). 'Iiis "' pSV2-
NEO derivative ob ta ined by mo difying ~SV2-NEO
(Southern and Berg, 1982) by replacing pBR322 sequences ~th
pML (Na kshatri , Pater and " Pater, unpublished) . This pl.asmld,
3634 bp (po-2) . fragm ents isolated, blunt -e'nded .with
\ '
:.-. \ .. ...:
r:
-1 ::
EcoRI, treated
containing the
HindDI anddiges~d with
transcriptase and the fragme nt
47
pSV2-NEO-pML,
with
SV40 early promoter (342 hPJ > plus pML (650 to 4360; Sutcliffe,
1979) was iSl?lated and ligated ~ith ea ch' of the above
mentioned HPV 16 DNA fragments,
Deletion mut a nts of E2 const ruc ted foll ows.
Plasm ids pT-57 a nd pT -48 (pO-7 and pD-2 de riva tives,
respectively; Figure 14, p 82) were constructed by digesting
each of the pO-2 and pD.? plasmids with Nd'I which cleaves
HPV 16 DNA ' at nucleotide 3126 and 3761 and pML DNA at
2'296. The resulti ng fragments filled In by
transcriptas e and the" la rgest fragm ents religated,
together. The" pT-57 and pT-48 constructs arc missing 635 bp
of the '- ORF ~th the d~tieam se~uences out Of . frame.
Th~..:::rtructs are also missing the . E4" ORF. · The plasmid
pT·20 contains "a 4 bp deletion generated by 51 nuclease
treatment of the BstXI site (2891). This 4 bp deletion places
the remainder of E2 out of frame. These plasmids are outlined ~
"in Figure 14, p 82).
A brief description of the plasmids used in this study is
given in Appendk A (p 154).
2.9 Cell euuure and tra osfection
African green monkey kidney CV~l cells were maintained in
Dulbecco'e modified . Eagle's medium (OME) with 10 % fetal
. .
such Ill.' . 11
Cells, (60 to
hours prior to
performed by
1982), Five
bovine and ) 'UPPlement: With Pen-Strep (5000 ' IU/m'L
penicillin; 5000 MC9t L streptomycin). The human cervical cell
lines C33A. SiHa and HeLa and the rhabdomyosarcoma cd !
line, A204 were obtained from the American Type Culture
.; Collection and I grown in the same medium as described above. .
The cells were passed by aspirating the medium from the te.lts
and washing the cells twice with 10 mL PBS (prospha tc
buffered sa line withou t Ca or Mg) . Th e ce lls the n
incubated in loS to 2.0 mL of trypsin·EDTA for approximately
15 minutes at' 37 DC and then resuspended ip pME .plus ~ 10 %
FBS. Th e approp riate amount of ce ll~medium mixture
added to 10 mL of. the same medium . For transfection
experiments, cells we,re seeded at equal density
plates contained approximately the same number.
70 % conf)uency) were fed with fresh medium 3
the addition of DNA. DNA transfections ' were
calcium phosphate coprecipitation (Gorman '-1 ~,
hundred' microli tres o f a CaCIz/D NA solut ion were, bubbled
slowly into 500 p,L ~ 2 x HBS (0.28 M 'NaQ ; 0.05 M HEPES;
2.8 mM Na2HP02 . pH 7.1). Th is fine, . cloudy precipitate was
then caref~lIy ad~ed evenly to the cells. For most experiments
a total of 20 'ILg of DNA was used per 100 mm dish (10 .Jlg of
I
test plasmid plus 10 ILg of pUC 19 plasmid DNA). For
experime~ts with plasmids expressing the ea rly ' genes of HPV
16.. a total of 2S I1g was used (.5 JLg of lest plasmid plus' 20
118 of plasmid expressing E2 and/or E7 ORF or -pUC 19 plasmid
"49
DNA as contro l). Four ~hours after transfeetion . the cells
car efully washed with serum-free med ium and subsequ entl y
exposed to glycerol (1.5 ml of 15 % glycerol in 1 x HBS) for 2
• minutes . The cells were then washed twice with . serum-free
. medium and incubated in DME plus 10 % FBS for 48 hours.
2.10 CAT assays ....J
Using recombinant DNA techno logy . and molecular cloning it ~
has been possible 10 ligate regu latory sequences upsfrea~ from
a gene which is readily expressed and has an easily assayable
. ,
product. Such a vector system, developed by Gorman and he!
colleagues (1982), utilizes the ability of SV40 regulatory and
other regulatory se quence s (such . as HP V) to co ntro l the
expr ess ion of the bacte rial chloramphenicol ace tyltra nsfe rase
(CAl) g~ The CAT vector system, used in this . study to .
me asure bj;"r:mo ter and/or enha ncer function in mamma li.an
a bsenc e of end og en ou s CAT e nzy ma t ic ac t ivities fro m
mamm alian cells, en~es Iha"t the assay is easily interpreted;
second, the assay simple, ra pid, sensitive, and repro ducible.
The transfec ted cell were ,h a rvested to assay th e CAT
activity by washing the -":' plate s carefully three times with 2
mLs of PBS (without CalMg) ; the cells were then allowed to
.s it ~t room' temperatu re for 5 minutes in 1 mL per plate of
Tris·EDTA·NaO .(0.04 M Tris Hel, pH 7.4; 1 roM EDTA ; 0.15 M
tissue culture ce lls, was chose n for severa l First;
thawed on ice ' and the pellet dispersedThe Irozen cells
SO
·NaO ). The cells were scraped (rom the plate with a rubber
policeman and pelleted by microfuging for . 2 minut es at 4 °C~_
The pellet was then frozen at ·70 DC until ready to assay.
by vortexing in 100 I-l-L (for ~3A, 1014, e12? or 143B
~ extraCTs) in 50 ,uL (for,. SiHa, HeLa. ' A204, and. CV·l
extracts) of 0.25 M Tris HO. pH 7.8. Cells were disrupted by
,re,pealed freezing and thawing: eppendorf tubes containing ' the
dispe rsed pellets . were immersed in liquid NZ for '5 minutes
J
then thawed in a wate rbath . set a t room temperature for five
minutes. ThiS cycle was .repea ted three times to disrupt the
cells. The cell debr is was pelJeted (5 minutes in a microfuge
at 4 DC) and" the supernatant waslransferred to ' a new tUb~.
One -tent h (10 jJ.L) of the ~3A (10 14, Cl27 and 143B) extract
or th ree-~enths (15 J.l.L) of the CV·l, SiHa, IIeLa and A204
extrac ts was ad ded to 1 p,L of (14q chloramphenicol (50
mCVmMole ) "-a nd 4 J.tL of 4 mM acetyl Coenzyme A. . Th e tubes
were incub~ted at 37 °C for 60 minutes before the addition of
ethyl aceta te , organic so lv e nt whtch extrac ts ' t he
chloramphenico l from the other reactants. The extract
dried in a speed vacuum and resuspe nded in . 15 p,L 'of e thyl
-ace tate. The sample was spotted on silica ' ge l thin layer
ch roma tography
cb lcramphen lco l
pla tes .
wdre
Acety lated
se para ted
and nonac etytared fp rms of
as cend ing by thin la yer
chromatography .(TLC) in chloroform:methan ol (95:5) .. The TLC
pla te trea ted with Omniflu or enha nce sp ray to Increas e
,
sensitivity and
51 .
exposed overnight against XAR·5 Kodak
film a t ·10 DC. After autoradiography. quantification of the
enzyme reaction products was achieved by liquid ecintilla tlon
counting of the . ecerylated and nonacetylated chlo ramphenicol
excised from the chromatography pIate. Data expressed as
"
.,
"
the pe rcent conver sion of chlora.mphe nicol 10 its acetylated
form -(% CAT activity).
.~
. ;J
~, ., " ", ..~ .-:,,;,~. , .
RESULTS
A tra nsie nt exp ression system used to. scree n the
noncoding region of HPV 16, 18, and 11 for enhancer and
promoter activity. The test plasmids constr ucted by
inserting the ncr ~agments of inter1st from ~ 16, 18 or 11
upstr eam of t he bact er ial chlo ram pheniCol ace tyltransferas~
(CAT) gene. These recombinant clones transfected into
cells and the amount of CAT activity produced by each
plasmid was determined.
/'
3.1 Ana lysis o r HPV.n cr/CAT r ecom bina n t plasm ids tor
enhancer and promoter activity
A computer search was executed and this search indicated
the presence of a putatrve HPV promoter ~n the downstream
• region of ·the HPV Wi, 18, and 11 ncr. Alignment of sequences
located in this region of HPV 16, 18, and 11 r~ealed the
prese nce of sequences similar to the promoter
se que nce s, TAT AATTA and GG~TCAATCT . (F ig ure .8) .
Suspecting the presence of a promoter, I assayed for promoter
activity in th~ ~oncoding region of HPV · 16, 18, and 11. In
HPV 11 experiments, the SS9.. bp 9ralllJSfaNI (7486 to 114) ncr
fragment was cloned into pSy q.cAT. The positive orientation
DOR.codID' region ~UtRce. of HPV 16, 18, and 11.
Th e following consensus sequences were written ~ the basis
of the sequence ' homol~gy . between the noncoding regions of
HPV 16, 18, and 11: (1) CAAT, potential CAAT box; (2)
TATA, potential ' TATA box; (3) ACCGN4CGGT. E2 binding
·- ,.: .. .•. ,." ;,..'::' ." " .", ,'.., ' ~ ~{.." ..., .. , . ' " , ' ..,,,:'",..... '", . ; .':
of the • .downstream
. ,
c:on'lparboDAlIgbmeDt andFllnR 8.
site. These sequences of the HPV 16, I$.. and 11 noncoding
re gions (nu cleot ide s to 100), obta ine d from previous
reports. were entered into a computer file and aligned with
one another using a NUCALN program,
O,T'. · 'r.•<. ,'!-.'"
,.
r; '.'
r '.
. ~
HPV 16
VERS US
:::s~:)
HPV 11 ,
.-
10 20 • )0 40 ~ O
~CT~C~ATMTTC~TGT~TAAAACTAAGGGCGTAACCGAAATCGGTTGA - ACC
~ATA~;TT;~~~~~t- --~G;~~f~f~T~~~~~~~~~~~~~~~~~~~~~~ft~GG~~~
CTTAATAACAAT - --CTT~GTTTA - AAAAAG~GGAGGGACCGAAAACGGTTCA-ACC
CONSENSUS :
, - - - ACAAT -- - - -- - - T - TA-A AAAA- - - - - ---ACCGAAA-CGGT'----ACC
60 7 0 SO 90
GAAACCGGTT-AGTATAAAAGCAGACATTTTATGCACCAAAAGAGAACT HPV 16
: : : : : : : : : :
GA1..\ACGGTG-TA~AGATGTGAGAAACACACCACAA HPV 18
GAAAACGGTTATATA TAAACCAGCCCAAAAAATTAGCAGACGAGGCAT HPV 11 -,
CONSENSUS :
GAAA -CGGT- ---TATAAA- ---- ---- -- ---- --- -- - -
" ,:.1.
pSVO.~AT eonstruet, whfc~ measures HPV 11 promoter
activity, gave 10-30 limes more . activity than the negative
orientation construct (compare p2 and p14; Figure 9). Similarly
in HPV 18, the CAT activity of the 1.1 Kb Ba!JlH1.pSVo.CAT
. :.;
pos itive o rienta tion constr uct (p29) significantly higher
than the activity measured for the opposite orientation plasmid
(pT-I3; Figure 9A). However. with the 1.866 Kb BamHVAvaU
fragment (6150 to 112) of HPV 16. little if any promoter
(enhancer) act ivity was detected in th e tr ansfected C33A
(Table I) or SiHa cells (Figure 9).
Next, enhancer activity was examined . by inserting the 1.1
Kb BamH (6929 10 119) fragment of HPV 18 upstream of the -
SV40 prom oter (pAI()'CAT) ' in both orientations, The negative
. orientat ion pl~mid (P9) gave . values . near that of the negative
control (pA lO-CAT), whereas the positive orie ntation plasmid
(pS) gave weak but reproducible enhancer activity (Figure 9B).
The HPV 11 'noncoding region was also found to function as
I
;t. .
an enhancer when placed upstream oC the heterologous' (SV40)
promoter. . However , ' unlike the BamHI HPV 18 enhanc er-
containrng fragment thi s 559 bp sequence cr lentet lcn -
independent (compare p5 and p6; Figure 9B). On average, the
HPY . 11 promoter and enhancer gave signifiCantly higher CAT
enzymatic activities. The HPV 11 promoter bad twice much
CA~ activity a~ the HPV 18 promoter (compare p2 ' and 'p29;
Figure 9A) and the enhancer .of HPV il wai six times
: ~ tronger than the HPV 18 enhancer (compare p6 and" pS;
FJgure 9. ExamInation or · tbe" BPV. ,16, 18,
region. ror enbaDctr and promote; CAT activity.
(A) pSVO·CAT promoter/enh ancer . series. (B) pA10!CAT
enhancer series.
transfected C33A
SiHa cells. The
HPV 11 and 18 result s from
cells while those for HPV 16 from
arrow indicates that the ncr fragment has
been placed in ,the negative orientation relative to" the - .CAT
gene. . The pAlO-CAT and pSV2-CAT plasmids were used as
negative and pos i~ive controls, respectively. Mast extracts
from pSV2·CAT transfected C33A cells were diluted "to give
a value within the linear range. The percent CAT activity
was' then corrected ; by multiplying by the dilution (actor.
The HPV 11 series of experiments had pAlO-CAT and pSV2-
CAT enzymatic · levels of 0.9 and 361.0 percent, . respectively
for experiment 1 (1) and 1.1 and 330.6 percent, respectively
for experiment 2 (2). The HPV 18 series had pAl O-CAT and
pSV2· CAT e nzyma ti c leve ls 0.4 and 1\.0 per cen t ,
respectively for experiment and 0.6 and 96.0 percent,
respectively for experiment 2- For the HPV '16 series pAlO-
CAT aod pSV2·CAT values were 0.5 and 13.8 percent,
respecti vely . Ior expe riment and 0.4 and 16.0 percent,
respectively for experiment 2- Trensfections and CAT assays
w~rc as described in Mater ials and Methods. Data are
expressed as the percent conversion of chlorampHenicol to
its acetylated form (% ~T · activity). Av, Avail; B, BamHI;
D,OraIll j Sf, SCaNI.
" .·,. r,, ' ''' ·' ' . , .:, ~\f .; . ; :
"
% CAT ACTIV ITY
pSVO-CAT PLASMIDS
HPV 11
pl'
Sf o
1.0 3.2
p2
o Sf
27.4 . 39 . 1
HPV 18
6~19 3.3 0.1
8
17.7 17.0
8
p29
pT-13 ~~:9__.!..,- ----::;
HPV16
pH .I\O" ~
Av
0.1 0.1
0.10. 1."I
M
p15 & 1~"'_ _:;
.8
. ;,;.. ..~ • • ! . . '
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B
'16 CAT ACTIVITY
pA 1O-CAT PLASMIOS
HPV11 P5 1)4 38.0 30 .9
Sf O .
ce 7~" 28.5 32 .0Sf
HPV 18
p9 'l' --, 'f' 0.6 1.5
B B
pSGlI21il
'" 6.0 4.3I IB B
HPV 18
p4 112 0.4 0.7
Av B
".. 0.2 0.2p7 S Av
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~b~~ ,Testing or the HPV 16 promoter add enbancer
These plasmids are as descnbed in Figure 9, p 56.
These plasmids are as described in Figure 12 ,p 61.
Plasmids % CAT Activity
'"2
pAUI·CAT 0.3 0.3
pSV2-CAT 145.4 148.5
pl7, i r 0.1 0.1
plSa 0.9 1.0
p4a 0.4 0.4
p7a .... 0.8 0.9
pT.50b 1.3 1.5
pT.3b 1.4 1.7
pT-6ob 0.5 0.4
-: J, .',:••
3.1 Characterization of enhanc er elements in the regulatory
region of HPV 16, 18, and 11
To localize the enhancer element of HPV 16, 18, and 11,
CAT plasmids containing subfregments of the ncr region were
construc~d, The upstream 837 bp of the HPV 18 noncodmg
region ' (lJT-46) gave about ten times more enhancer activity
than the fragment (p8) which ret ained the ear ly .region
proximal 210 bp sequence (Figure 10). In addit ion, deletion of
,, ~equences from the upstream portion of the noncoding region
found to slightly diminish CAT activity .(compare ' pT-46
and pT, U j Figure 10). Interestingly, orientation dependence
observed when the 837 ' bp (pT.46) and 347 bp (pT-Il)
fragments of HPV 18 were cloned in the ' opposite orientation
relative to the CAT "gene (pT.4 and pT-2, respective ly; Table
II). However, the 230 bp Rsal fragment, generated· enhancer
activity in an orientation independent manner (compare pT-81
and pT-18; Figure 10); this is in agreement : with a previous
study by Swift r.1 nIt 1987.
The results from CA~ assays given in Figure 9A and 98
indicate that the DralII lSfaN I 559 bp fragment from the
noncoding region. of HPV 11 DNA contained all the elements
necessary for promoter and enhancer function. Removal of 175
bp fr&l{I ~ the downstream po rtion of this 559 bp fragment
. Various restricticn .fragmenti of . HPV
.the . pAl~:r vector. as descnbed
18 'were cloried ,-.....~to
in Ihe Materials and
. .
Metbods . Plu mid s pSV2·CAT and pAlO -CAT
i!-ansfred .as controls into' C33A and gave 174.0 and 0.6
perce~1 CAT ,,"ctivity, · respectively for experiment I. The
CAT .; assay values for experiment "'2, were 174.0 for pSV2·CAT
and 0.5 percent for pAlO-CAT. A, Acd; B, BamHI; R,Rsal;
Sf, SraNI.
,
\ fl
;:".
. ..,~ ~,~...,~.
% CAT ACTIVIT Y
p8 6929>-
B
pT~46 692 9..
B
pT-11
pT-8 1
pT-18
.) 1 2". 4.4 7. 1•B
" ..77 66 40.4 60.5 . ';~
A . ::;
7 4 19 7766 19.3 43 .5
Sf . ;'A,
7 5~ 23 .3 32.0 ..;-
. . .,R R
77 38 f- 7508 19.5 34.0I
"R R
..
..:.,:;
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HPV ·,18 DoPtodial regloa enhancer
Table i IL ExaminaUOD ...er the or1eDtatioD-de~DdeDCle or the
Plasmid. HPV 18 Fregmentl
,
% CAT Act~vity
pA I6:Eu 1.4
pSV2-CAT 89.88 ...
p9 BamHl (119 to 6929) 6.5
p8 BamHI (6929 to 119) lOA
pT -4 AccllBamHI (7766 to 6929) 4.4
pT-46 BamHVAccl (6929 to 7766) 528 8
pT -2 Acd lSfaNl (7766 to 7419) I .
pT-ll SfaNl/Acd (7419 to 77(6) 52.28
a
The -percent of CAT ~ctivi~ (in C33A) ~ above that of
the linear range, ' resulting In an underestimation of
re lative CAT activity.
r
/
•...'
64 .
enhanced CAT activitY [compare p6 and p!-2S; Figure 11). By
e xa m i n ing differ ent sUbf~agmc'n ts for CAT a c ti v it y, th e
enhancer ' o f HPV 11 . was loca lized to II 2p bp N~eIJSauI (7657
7870) fragm en t. Ag ain, removal of se quences , from the
upstre am portion of "the HPV noncoding region resu lted in II
lowerin g of CAT ac tlviry
Similarly, each of the H PV 16-ncr/CAT· recomb inant plasmid s
wer e tran sfected int o SiHa ce lls and ass aye d for CA T ac tivity.
No sig nif ica nt le ve ls o f CA T .," ac t ivity above that · of th e
negative cont rol, pAIO.CAT, we re detected in cells tran sfect ed
with the HPV 16-ncr/CAT plasmid s (Figure 9A and 9B) . To,
test wh eth er rem ova l of 238 bp from the down str eam portion
of t he BamH I/AvalI fr agm en t wo uld re su lt in d e tec table
e nha ncer ac tivity, I co ns trucled . pla smid pT . 50. Thi s plasmid,
a lso missing 288 bp from the upstrea~ porti on of th e ncr,
when transfected was found enhance the CAT activi ty by
op 25 fold (comp a re p7 and pT.50; Figure 12). Th,
e nha nce r activity of pT-50 and "another plasmid re taini ng the
55. bp fragment (SspllHphl; 7224 tn 7778) of the ' HPV I" ncr
.. (pT-3) was r e la tivel y weak (c o mp a re d to pSV2-CAT) but
reproducible. The H PV 16 enha nce r was further localized to a
315 bp SphlIHphl fragme nt (p T-69; Figure 12). Th e a ctivity of
'., ~ the ~n ha ncer fragme nts
se q ue nces removed . Thi s
to dimini sh as j the
was simil ar to th e
upstream
sit ua tion
observed in HPV 18 an d 11 enhancer subfrag ments,
\
•
Flaare 11• .Loc:albatJoa of the HPV,l1 eDbuttr element.
The HPV 11 enhancer pAlQ.CAT constructs (pe, pT.2S, and
r '" pT) AS described ' in" Materials -a nd Methods). the
~:. enhancerless pAlO-CAT vector, and the enhancer-positive
(-- pSV2-CAT clones were trensfected into C33A cells. CAT
. enzymeJ'" levels for pAID-CAT and pSV2-CAT were 0.3 and
~.I
..
716.0 . .percent, respectively Ior experiment
713.0 pcrcen.t. " reJpectivc?, for experiment 2.
NdeI; S, Saul; sr, SraNl.
. ;
and 0.3 and
D, "DraJJI; , Nl
.""
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The plasmids were constructed as described in " Materials and
Methods. The ,pSV2.CAT and pAlO-CAT plasmids, . when
transfected into SiHa cells. gave- CAT assay values of 44.6
~f!d ' 0.8 ' percent, respectively for experiment 1 and 35.4 and
' ,
1.0 percent, respectively for experiment 2
B~mHI; Hp, Hphl; Sp, Spbf ss, SspI.
, "
Av, Avail; B,
•
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3:3-Jbt~ 16, 11 and 11 eohantttl are cell type Ipecl.nC
I
1 Papillomavirus.es 'have a highly restricted host range and
grow Iytically . only in differentiated keratinccytes of epithelia
(Broker- and B01Ch8~, 1986) ." . To check whether enhancer
activity can be correlated with cell type specificity, the HPV
16, 1~ and 11 ncr enhancer constz;uclS were transfected into a
range of host/cell . types. The results shown in".Table III
indicate thai the HPV 11 enhancer appears to function in a
wider , range of cell 'types" 85 compared to the <enhancers of
HPV 16 and 18. The HPV 16 and 18 enhancers were restricted
in activity to cell lines deriv ed from human cervical
carcinomas. The HPV 16 and 18 enhancer constructs were not
active in the human fibroblast cell line, 1438 or in the human
rhabdomyosarcoma cell line, A204. The nonhuman cell lines,
CV.l. a ~0~~7 ...k,idney derivative, and the mouse fibroblast
el27 also gat negative results (or these regulatory clements.
Interestingly, the HPV 16, and 18 enhancers were also inactive
in· the C127JBPV I transformed cell line, 1014. Therefore , iI
~~OUld appear 'that most of the epithelium-derived cervical cell
". iine~ ~onl.ain the factors necessary to support HPV enhancer
ectlvity.. This also correlates with the. strict tissue tropism of
th~ viruses. On the coptrary, the HPV 1I enhancer appeared
10 'be active in both , cervical and non-cervical cells alike.
-... ,., ' .(
Correlation of 't he' cell-type
enl1ancer witH · lu ~I) tropism b
. .. "
specificity of the
discussed later.
HPV 11
70
/
ceu lines :ili:lP~ ::~:;r
HPV 11 HPV 18 HPV 16
Cervical carcinoma
+b +bHeLa (18)~ +
MEl 80 (18) + /
+b
MS7S1 (18) + + +
SiH. ( 16) + + .;J
CaSKi (16) +
C33A (-) + + .I +b
Human fibroblast
1438 (.) NOe
Human rhabdomyosarcoma
A204 (.) +
~~lk7-) kidney +b
Mouse fibroblasts
cur (.) NO'
10 14 (SPV I) NO'
.
The numbers in the brackets indicate the HPV type
Integrated In the cell linc; (-) Indicates there is no
known HPV DNA present in these teU lines. This
~roW~iiO~a:S a~~rPaI~rr~~9gs~~: ~u~\ 1~~~h8r1 ~
b ' ,
.. These CAT aClivities ore Just above"'Mckgroun~.
c
NO: not determined. tI
'.;~ :~~_ . -..
,
'-.1
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of the HPV 16. ra, and 11 cell specific
also involved transfecttng the ' HPV/CAT
,
..
Further ,comparison
~~hancer activities
constructs into three .cervical: carcinoma cell li~es(HeLa. SiRa
and C33A) and one noncervical .cell line (A204). The HPV 11
enhancer ~ stronger - than HPV 18 and 16 in aU the cell
lines examined. In, A204. a no~-cerviC81 cell "l ine, l .the HPV 16
and 18 ncr/CAT constructs gave no enhancer .activity; .it was
the same as ,that of . pAlO-CAT while 'the HPV lllCt\T plasmids-'
gave CAT.. enzymatic activities much higher than th~t of the
ne~ative control (pAI~CAT). In fact. "the enhancer a~ l ivi ty of
HPV -11 was 40 % of pSV2·CAT activity. The relative strengths
~ of the enhancer elements from the oncogenic viruses, H~ 16
and ' ,IS. varied depending upon "the cell type. HPV 18 enhancer
activity was higher than HPV 16 in C33A. <> cells, whereas in
SiHa the reverse was true (lanes e and f versus lanes g and hj
Figure 13A and 138).
" In those cell types for which the level of HPV 16 aneJ/or 18
enhancer acti vity above background, fIR incre ase in
activity wa; ! observed . with the removal of approximat~ly 200
bp comalning the putative promoter region. For, instance. in
C33A the CAT aetivt'" obtained ~th th~ HPV 18 . ~cr-pA1()"
CAT (pS) . co~~uct was 10.1 ~rcent, whereas. that obta ined
with pT.46 was 48.0 percent ' (Figure 13B). A similar tendency
was . found when the HPV 16/CAT -, recombinant , pla51~ ids were
transfected into SiHa cells and HeLa ' cells (compare p7 and
pT·SO; '~iil:'re 13A) ' 'and to a lesser extent when the . ,HPV .
Flpre 13. Cell type .pedDdty or .HPV 16, 18, and 11
. enbaottn.
) Auto rad iogram of CAT assays . from trensfection experimenu
, in: ' (A) · HeLa and SiHa cells; ' and in: (8 ) A204 and C33A
cells. The extract .(rom C33A cells transfected with pSV2-
CAT · was diluted by 10 fold. Plasmids were: it) pAl~T;
b) ·pSV2.CA:r; the HPV 11 . constructs, c) p6 an~ d) .pT.25;
the HPV 18 constructs. e) p8 and f) pT-46; the ' HPV 16
constructs, g) p7 and h) pT·50. Numbers at the bottom of
...'~
eac h a uto r adio gra m percent CAT activ ity. eM.
chloramphenicol; AcCM, eceryleted chloramphenicol.
f ' .'. "
t,-. . :
"'.~_.: ,.1 ' 1.. . .. : . ' .'._. ' .:.)-;,
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tested in C33A (compare p6 and pT-
difference in enhancer activity prompted
the removal -of the' promoter sequences .
(i.e, TATA box) alone . can bring about this increase or i~
oth er upstream se quences ac t · ,aiegatively to repr ess t!tis
, activity.
This was determined by ~:mining the effect of progressive
removal of downstream sequences from the ncr of HPV 18 •
(fable IV) . We used HPV 18 for these analyses since p8 had
gener at ed a signif.icant increas e in act ivity. with removal of
the downstream 210 bp fragment (Figure 10, p ' 61). When a
shorter HPV 18 fragment (BamHIIAvaII) was tested, the CAT
activity increased slightly (compare pB and pr-~9; Table IV).
The . region removed trom " the BamHUAvall fragment contains a
TATA box which might have interfered with the distal SV40
promoter (Wasylyk et al, 1983; Hirochika et al, 1981). Removal
\
of a further 60 bp from the d, stream portion of the
BamHI /AvalI Cragmen t also in cre as c ~ . th e CAT ac tivity
significantl y (compare pT-39 and pT.~3 ; Tabl e IV). Th e
fragment BamHJlAccI was also tested .~ d the activity was
found to increase further with removal of J hC 88 bp Acc/Bbv
fragment (compare ~ pT-33 and pT-46; Table IV). Data presented
in Table. IV . suggests that a negative reg latory element may
be present In this 88 bp fragment.
- .
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% CAT ActivityPlasmids
Table IV. Examination or . the tired or
deletions on the enbaDctn or BPV 18 ,In C33A
•
pAl~CAT
pSV2-CAT
p8 (BamHI; 6929 to 119)
pT·39 , (BamHUAvaJI; 6929 to 56)
pT.33 (BamHIIBbvI; 6929 to 7837)a
pT·46 (BamHUAccI; 6929 to 7766)
0.3
716.0
15.2
22.2
45.2
50.3
0.3
713.0
17.5
t .
24.4
46.9
57.0
a
The Bbvl site is at nucleotide 7837, however treatment
with reverse trenscrtptase results in an endpoint at
nucleotide 7854 (Figure 16, p 98).
position3.4 Examination of the
the HPV 18 enhancer
77. /
and ~entation
,
dependence' or
Next, the position and orientation I dependence of the HPV
18 enhancer exa mined by pla t ing the 347 bp
(
\
subfragment downstream . of the Cf-T gene. Insertion. of the ' 347
ba HPV 18 enhancer (SfaNUAccI) fragment into the.Xbal site
of pAIO.CAT in e ith er o r ie nta t io n (Figu re 6, p 42)
dramat ically decre ased the ability of the 347 bp . HPV 18
fragment to e nha'nce t ranscr ipt ion fro m th e CAT gene
(compare pT.52 and pT-] I; Table V). Interestingly, placing of
the $V40 regulatory sequences downstream ' Of) the CAT gene
also greatly diminiSh, its activit,l (see pSV2:CAT and pT-42,
Table V). Th e orienta tion effect of the HPV 18/Xbal
(downstream)/pAIO-CAT constructs (cCIilPlpare pT· 52 and pT-53;!
~ Table V) was similar to that observed with the HPV 18/BglIJ
(upstre a m )/pAIO -C AT co ns t ructs (co mpare pT-2
Table V ); th e grea tes t activity obse rve d
a nd pT · l l;
•when th e
enhancer (the Accl border) was placed nearest to the SV40
promoter (either upstream or downstream).
3.5 Ana lysis or seque nces requ ired ror IIPV 18 pro moter
ru...~dlon
Promoters are requir ed unid irecti onnlly for nccurnte nnd
efftcient lranscription, ~hereas enhnncers ' lncrcnse the role of
' ,'
· Table , V.' Examination or tbe erred or position and
orkntatloD on the HPV 18 ,ubl.Deer
Plasmid! % CAT Activity
pA lO-CAT 0.6, 1.4
pSV2-CAT 344.iJc 89.8b
pT-42 5.5 6.1
pT-51 Ll 1.6
'"
pT-52 11.9 9.6
pT-53 1.5 1.5
pT -2 11.8 ~
pT- lI 78.0b 52.2b
a . .
For a description or these plasmids see Figure 6, p 42. .
b .
The percent or CAT activity (in C33A) is above that~
the linear range, resulting in an . underestimation or
relative CAT activity. .
c _
This pSV2·CAT extract was diluted to 1/10 relative to the
others. ' .
\.
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'from",~-1ink.ed .pr om oters _ i~ ,
manner \ (re vle;ed
transcri ption"
independent
. attempted ' to ,identify the '~I "~ sequen~ re~uired" "
18 promoter function. The e~hance~!promot~r .~cti~ty
HPV 18 1.1 Kb & mHI . fragmeni (p29)-" was "further
a ,\ 404 bp BssHIJJBamHI . (75.72 ,to 119) fra~tnt "
7, p 44). The BamHI-and BssHII/BamHI
activities. of similar values. (compare p! 9 and pT-29, T~ble VI).
Since these plasmids have both- the' enhancer and the ' proinc'ter' - ....
in the sam~ orientation , the enhancer fragment (BssHIUAccI)
of HPV 18 was ' placed in the . negative orient~tion ' relative " ·to............
the HPV promoter , (pT-2B; Figure 7, p ' 44). This would indicate~
whet~e.r ups~ream ~ e nha ncer seque nces ~ere required for
. promoter tunctlom, The-.' result; -" shoW~ • that sequ~nces ' .. from . the
HPV 18 enhancer were required unidirectiomiUy ro~ HPV " 18
pr omot er function (compare~~.29 and pT.2~ , Tab le VI) .
Insertion of this BssHIJJAccI"'-grnent /into' the. BgllI . ' site 'cof
, '0. .pAI0. CAT generated a negative orientatio~ construct (pT~37)
which, ", 'when assayed for CAT activity, clearly indicated that
thi.s fragment by - itself is capable
negative ,prie~i8tion<,relative , to a
~. VI).
0\ enhancer function i~ the
heterologous promoter (Table
\
..;J"
- - " -
~e pSV2~T_(c;J3A) c~ract , from expenment 2.~s not ,-
1~~ut~V~~~T~itjs~~et~tl.or:~e .ijf~~~~t r:~~~ty->
resulting in an underestimation of reJat~e act~vity.
For a description of these pJasmi~ see, Figure 7, P 44.
Plasmid . % CAT-Activity
./ .
I ' 2
. pAIO:CAT 0.6 1.4
pSV2-CAT 296.0 89.ga
pT-13 0.1 1.0
.. p29~ <,-~ 17.0 14.0
pT_2?b 17.0 21.0
PTib 1.0 0.9
pT-37b 14.9
,,~:':0'~:~/~0ilr~:~ :_.'~;)',~~:~; ?::~";~'~'~:'~-~:~::~:'~1':;' 'i '~~?-_ :i;IJ~]-~¥~~~~~,~
,'. , / 3.• ""Tnuu-..... lado. of Ill. HPV '.. '8, ond 11 .D!J,oeee~ b1 ,. ',-'
r.. .!the E1.anci~~;:~r ~ 16 . . " - ~~
. . . .
e;p"ression is be lieved to mmlve .a .Th. contro l of viral g...
viral cis-acting elements with viral 'pld
. ..~
. ~
:,
.,
product(s) is lower' ...'..
HPV ' 16 and ' :11 [/l
marginally stimulated from O,~8 percent' : to'
results suggest , \hat . the relative amount .' of
increase: in CAT activity. /U' shown in Figureresulted in
"enhancers.. A deletion ~ of" 63S from the E2 gene (3126 -to. ~761)
~ co nst ructs wuh " th is ear ly regicn -expresstng plas mid . (p O· 7)
14, . the HPV 16 enhancer .was trans-activated .by 7 fold, the .
HPV p enhancer by slightly less than S· . fold, w1ute the HPV
cellular :ra~s.acling factors. - Cts-aeting elements located ' in ' : ~
the noncoding "1'Cgions of HPV ' 16, "18, and 11 have been sho:n·
10 respond 10 trans-activating ' rac~ors encoded b~ . " th~ ~PV 1
and HPV E2 O~Fs .~heIPS ' and !J_~~Y. 11987; Hirochika ,.'1 ~
1987; Thierry , a~ Yanlv, 1987). A repressor .function has also
" ./ . . ..... .- - . . . ' . , .
.,./sh~ _" to . ~. .~.ssQciate~ . r .the .~r~ermi~L ~e~on .ct t~~
BPV' 1 and HPV 16 . 62 , gene products (Lambert ~ .a1 1987;
cri~e ~ .d '.&1 ,1987). . To •.:rurt.h~r· .characie~ize . "the . reguJato~
function .associated . with' the early rcgio~ of HPVs, most of
the early. genes. ,(E7, E1, E2, E4, ' and liS) of HPV ~~. - we~' · .
exptc.ssecl under the control of the early promoter pf SV4Q
(pD-7). Cotransfeetion of the HPV ' 16. 18., and 11 ' n~ICAT
18 enhancer
..
---:....0.77 pereene,.. These
d ..~·
trims-activation by the HPV. 16 early ORF
for the HPV ' . Ig enhancer than for the
•.'•...) ~., '
;' .
\the deletions
represent ' HPV ",. 1~
16 . ear.ly .r egion
I;IP~ 16 early region express ion plasmlds, -a re-
In . M,ater ial';\ and Methods . · . Plasmlds used were:
p7; HP~ ·11, p6; HPV . IS: p8. Th. map .r HPV 16
~~T . , or
described
HPV 16,
~~s aligns - with _ the solid lines ~hich
sequences": pre sent ." in . th e five - HPV
~ression plasm!~. . D~~ed ' lints indicate
..: ~e .~g1e depicts a 4 bp.deletion,
·",l~~~W7'~··tJ··Zt~'~~rr"~=~'"HO;~' ':" ~-: -=. :,~; ·· :1
t> -. , ~ ear JY ~gion ~lasmi~ ~r .20 p.g ' of ~pUC 19 as ',. coniroL --;~ :jg ,'S ~g -cf . pSV2-CAT or pAlo.cAT-Was tra nsfected with ' 20 p.g - . ".;
~( of pUC 19 into these -ev~\ monkey . kid~CY u .1;ls and ' "gave
. , " . _ \ . _~ t
the . enzyme 1lctivities of 33.9 - and 0.1 percent, respectively.
.--- "
4.00 0#7 ..
0.33 0;20
18.86 2.63
0.30 0.28
1.-18 " 0.24
0.86 0.48
I
0;17
0.38
0.20
5.40
0:32
, ,"
4'334
.....
~"EJ =1E5T""""1--. """7:(,:---:-11
. '1, L, . " I1 -Y==1
700 4bp , ;12891
.,
~Hpa 11
'00
" Hp~ II
pUC 19
IE11!:11
o
a . "'ATAAA 'J, ATAAA 7904
I \ , ! • , ,
,,*,CAT ACTIVITY
#
----. I
HPV'16 HPV"l1 HPV 18
PD- 7 50 1, 4334 " ~I1" 15 . 'I I ; . -
Hpa II Sau ~ .
pT-20
pT-48
pT~57 , 5~ 1 3 1~';_ !7~34
HP a. II "Ide I Md. I sa~ I
pO-2 ... · 7~
Hpa II
d'
~ .
function
pT-48 and pT·~7 . _!.~ ~_'- .__....
the ' E4 ORF. therefore to
The
~~constructed. " The , 'P1as~id '
placing . a fn!meshift ~util:tjon in ' the
., . .- .
amino- tel'ttl4'ta1:. porion of the , .£2 gene at the BstXI site (2891)
of' , p~.i~ · t his ,\~am~Shift :muta'tio.!!. should " only affect the "
~1~tiQn .' of ; the . E2 ORF. Cotranstectlon e~riments of . the
H~V " ' e~hancer/C~T constructs ' with ' ihis -"deletion' mutant
con clusive -, evide nce that th e HPV 1.~ BZ, ' gene,- .
. above) plaSmi~ also missing
further localize the trans-acting
another deletion mptant plasriIid1-:
',j
-,
.',
: : ~
anal yzed . to
or translationthe deleti~n . .might hav~· · altered the st,ability of
from.a mod~~ mRNA transcribed from the pI?-2 plasmid.
The mecha nism of t jansregulatto n
\
l'1q!;~,:~ q~fj~rt~~?;I:!~7" j(':!y'~'0~!:);;~?~,~+)!\~~'~fj~?g?!(S(;ffij~!:
{ . .p~uct aloOla.is responsible for the observed trans-ectbetlcn. , . i.j
: ; eoinpari,on, of _ the ~;";og . fun~ionJ , ' ~f pD-7 ~ 'P~2 - ' " ;",;,~
-: . has- design~t~ a . repressor function t~ .• the E7 'ORK To .vfurther ..
- verily - !ranJ·regulation ; by each - of th~ 'E2 and, E7 ORFS; the '-- -, ~}\;_~,
enhancer -plasmids ":cre ' ~tra~f~ed . with .two constructs. :(
" ' f . .~apress~g.." thee .E~ . 'OJW (pO-I). }he .other ..expressing the'; .E7 · ~~
~:s.~~:-:~~n Th:f '7:~tt ::::::: i:yTal:: v~: \oe:~ , 'IS:: ]
repression .of this activity ,,' by the. E7 OR F: Th~se 'plasmidS \ also
contain _th'~ El , ES, and in. ,.pD-2 lh~ . E1 9iFs. 'Jr,v,,:,' as
. demonstrated ' above, these '; ORFs do. "not "; ~ncO~e prod~CLs· ~h!Ch
i nvo l~ed _ in trans-activation trans -repression of viral
. ,gene functicn, P~mld . P~-48, ~nt~ ining. : -: de lel io~ .' i~ " both,_i the,
E2 and E7 ORfs,· ·was' u~ed · . as .a co~ I~I . in : these. exPeriments
to . dern~nstrat~ th81 the negative effect of Ei. . frOm : PT-S,7: is .
not due 'to ·.other · HPV ·'16 SC:9.!!:~,!cei. , '~e data , ' in Table ; VIJ
also' rule out . the possibility .tbat the results in Figure 14
might be due to: 'cis effects: from' .the '~~ . deietip~ ' ~or example; "
determine whethe; the HPV ' 16 E2 ' and/or E7 , involved the E2
binding' motif, ACCGN4CGGT. ~~V , 11 _enhancer : plasmfds : ~ih.
four (p6; ' DralIIISfaNI), ~ne ~(pT-7S; ~raltt,s~ul) ·' ' ~r , n~:¥ I ',
.. .l i Ndci~uI) ' ". of these E2 binding' ,m~tifs (Figure : 17, . P 10~ ), '
. were cotransfected" with . either ' the E2 . expressing plasmid, -. p~. ,
"
?'
" ,
;<I~'~l~~rr.;~!Y~~~~;TS~\i~:;~f~;Y~5i;f;"1J'1:f).~:;(:fr:'d;~~(;;~;:ftS~{jJ~,
,,':-
plJ.2 + pT48 . SA .' 30,4 . 4.7
plJ.2 · +.pT.S7 1.8 .7.8 3.2
pUC '19 1.8 10.8 1.6
:,Table' ,vn.'-;Ei traas...etlYatfua 'and ,E7 rtprelsloa''or the,HPV
", '- ' l~ - 1B, ,~Dd . ll enhaD~n ' . . .• ' ..';;.;;~ ~ • . _ _. ~ , "
Plasmlds. :. %. CAT Activity ,
HPY 16 • HPY 11 HPY 18 ·
.'
3.7 "TrU I:a! u ,.. 't10D by the '£1 cue ' prod uct Is · mediated ,
·throup 'a h;te~l0&0u, hat nnt a hnm~i>gon. promote, .
.The .L, function of '·the E2 . gene, d=nbe<l ,
a~. iWas 6 amined .~ing the HPV . 1~ 18, lind 11 !Joncoding .
· regionI; in I n , enhance/ conf iguration'. (I.e: the HPV enhancer
~agmefts aJ .und~r . the contra; ~~ .\~e , ~v'40 early promoter;
see raslJli~ l p7. · p8. : and . p6. ~ respectiv\!y. . ~ilP,ll'e . 14). , I A...,ext
examined . the effect oC cotransCection with plasmid pD-2 o.n
lhe!ae;lvity t~f ; eo~st,uets . ecnteinlng t~e .: HPV.· ncrs in a
!-.,::t c .,1\: '..,. .• - .' .:r ' .• .•\ .~. ::.:-~
. I
;- .
. . , . J
I ~':.' " '•. _ ~ •• l , . 1-0:;
lr~i\ (~ " ~"\<~"'. ·~ :~:':::?\r~~~·Q!~:.~·~;: : '~:Jr~''i~. ':~S1''':~~I;i~:";~\~,?t'\: (~~~
• 2, " 01- the. E2 ' and ; . E7 .~ing.' .p1asmid. ~ , .pf).7. ·· The 'results .\ . . ~._.;;
. (Tabl~ --'VITI)" \~~te : ~t . tranS-activBtion by . lh~ E2 . ~~ .: "J.
requires the' E2 'bindin g matif (oompare · ihe cAT . activity. "of p6. • -.,
. / . ,
~ 'pi -2S to ' trn;.t or pT-t when ootransfee:tcd. with .p[}.2). A
similar ObSCl~l.tIO. \ has beeo.;"'de by olhen (Cripe' <l aL
1987; Haugen J ~ 11. 1987;- S~lhOlz ~ DL. 1987)." Cotransr~n .".
•, . i . ' • - - . .'
· 0_( . th e .· ,pS~2.:..CAT ~IBsmid Vljth the. ,E 2 expre ssing plasm,~~
resulse . in little if any increase . in CAT. activity. · However, less, .
: :::r:n:f::'~d . ( : : th. ~:~:il\7~:xpr:s::::ne~~las:i': ' :'SV::;'re~w~:: .
the activity of pS~2:CAT \ when transfected with . ) UC ' 19 .aloneor~ with . th~1 pT.4'8 deletion miitant plasmid . (Table . IX) . If is -
important .'°1, "note:, ' thai' " r~pression . ~f 'PSv2 -CAT by " the E 7 '
\ ..
gene produc1 .does not directly iIwolvc .~ E2 bind~g ' motif
since such. sequences are not present in pSV2-CAT.
I
~U':.I/'.. •• ' ~,';.,t {':I·j Jq} 'l' ''Ji.' \i"'l:'~, t.ra;,;~:r,."jo::;y:.:..". ;!,V:...t\ ?~,r;~..i]'ir'Yi·'t/i ~V':,:~ . 3"~. ~~)~~ "'~~:f~~~~~~:~~~~:'! ' :':: '~>~~~ ~':'::~:88;;' : .:" " <~" .: "" ': ." '\~ : :'( '~;'.'~ ~': .';~;-~:~
;i::., .- '.: . 1 • Table . VID. R.-mn. ear . of the. . D. blDdJq l motlt. 'for tnDt- .. ~.J
; ,: . ' lC1I..tIoa by th" £2 . ceDe prod"" . . ' '. '~
{) . ~~~ ;'';'''ber 0; E2 ~tifs % CAT AtUvity . ...Jj
"t · "'> l p~~ 19 ' '''; ~il'2 . pD-7 . ...~
~~ - -:_. p6 - . If 5.2 . n.~ 10.1 -;~:-. pT-2S s. . ! 5.7 ItO 9.3 ""
~, ,, ' P: -! 0 . . 1 ' 7.4. . 9.3 5.1
'.b f(tTh:c~~\gT ~Ya~~~~llsga:SaT~~e~ ~r .~r(no(
. ~~~ted) and 0.3 percen,t,. re~pective ly. I
1.'_ ,'
' :.. '
h
~'; '
.e:! : . '. "0.
J~I?rw:;;:,'(;~d';rr~' '': '+ i';~'!'?;~V.,';:':~Z;''''f ';';;:';' ('7\~-"';u;;r:c::;~ ;:: r~~'~:::\'~'f\~i:~\
. ~ / ' \ ~ ,
!~
Table IX. Effeet or E2 aud ~7 leDe productl Oq tbe SV40
rqulatOl)':sequences
PlasmIds % C(\T Activity
!
<,
pSV2-CAT + pUC 19 25,6 20,6
pSV2-CAT+ pT-48 25,4 ,. 20,1
pSV2-CAT + pT-S1 11.0 1.6
pSV2-CAT + pO-2 26.2
Five,micr~ms of pAIQ-CAT was 'C<?transfected alon~ with 20
. ~~;nrO.~u in -l~lr,sm~~lS~.~fmi~~r ~e5c:: ~r~V~CAT o~s
cotranstected with! 20 J.tg of pu3 19 or HPV 16 early region
.expression plasmJds (listed above).
/
I
/
I-
I
I
I
..
. ' and pT:Z5, re spectively) are compare d in cc tra nsfec tton
experiments.
~rted ~ into the pAlo-cAT plasmid (pT-50 for HPY 16, pT-46
. . r
. for HPY 18, and p;-25 for HPV 11) and the resulting
constructs when cc transfected were trans-activated by the _ EZ
gene product (Figure 15). These results reaffirm the above
observation that · one ~ binding motif is sufficient for EZ-
med iat ed trans -ac t ivation. Si.milar ac tiva tio n i iftios
Pb~ined . whpt .the HPV n~r enhanee:r plaSm~ (p7" pS, . and p6)
and the HPV· ;deleJion ' mutant enhancer plasmids (pT·50, pT-46,
motif,
.,re spec tively) was • not
pD·2 _ (Figure ' 15). Fragments-
and the . upstream .) ;'. binding
in th~ absence.
'\
-.Ibe enhancer and :promoter/enhancer plas~
18. ' a~d ri ~re · trans:rected into cv.i . cells
. ,
(-) or presence (+) of pD-2 as described in Figure 14.
of HPV 16, ,
..~
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DISCUSSION
,;"
.,
: ,~
.,
Th e ~tudjes described in thiJ thesis were undertak en to
• ~hc;f an un,den tanding of the regulation . of human genital
papftlomevirus (HPV 16, 18, and 11) gene expression. The
objectiv~ of this, study were (1) to identify the cis-acting
eleme nts (l .e. e nhance rs/ promoters) necessary for the HW
noncoding region promoter functiop and (2) ~detcrmine "
whethe r viral and cellular factors were' involved., regulating :' .-' ,
expression from these ' sequences. The data presentp in this ,
study demon strate' tha t ~ rans.c r ip i i ona l promote r and/or
enhancer exiSls within the noncoding region' of HPV 16, IS. ' , :'
and , 1 ~: . The se enhancer element s . were also" shown to .. be , "- ,
responsive to the negative and , positive. vital factors encoded
by t~e HPV 16 E7 and E2 ORFs. The constitutive enhancers of
HPV 16, 18, and 11 have been localleed to 31S• .230, and ~13
bp fragments, ' respectively, Comparison of the DNA ~uenee
homologies. of the viral enhancers indicate tbat ' the
. -
H PV 16
and 18 enhancer elements are closer in seque nce homology
than' either HPV 16 or 18 isI to the HPV 11 ~nhancer (see
below) . The sequence relatedness of these HPV nQncodin~ _
regions cor resp onds. 10 the dirrerenc~s in cell . specificitls
observed " among the HPV 16, 18, and 11 enhancer elements.
The restriction of HPV 16 and 18 enhance r function 10
. ".
, : .1 : ' '. -: : : • ...; • • v " .,~ _ :. .:yo'>
.,.
94
'cervical epithelial celts is contrasted "to . the relatively, "'b road
cell-type · expression of the HPY 11. enhancer. This allows (or
correlation of ~nhancerspecificity to the differential tissue
tropism and pathogeni~itt observed between ,th e human
nononcogenic (HPV . 11) 'and, oncogenic (HPV 16 ~nd 18) genital
papillomaviruses.
4.1 _ ldenti ncatioB . or promoter aod enhancer activity in the
noncoding regions or HPV 16, 18, and 11
Promote~s defined as cis-dcting . elements which
required ' immediately upstream of 'and in -r-t he same orientation
(positive)\ l as linked genes to allow transcription , whil e
I I ,
enhancers orfehtauon-Independent (Sassone-Corsi and
Bonelli , 1986). Comparison of the noncdding region" Je~uenc~
. of HPV 16, 18,. : and _ 11 ' indicated the presence of promoter-like
, ' .
.sequences near the amino-tenninal portion of E6 (Figure 8, p
53). Previous studies 1\ of SV40 and BPV have localized
enhancer and promoter functions upstream " of the early genes
of " these viru~es (Ahola -'1 .ill, 1987; Benoist and Chambon,
1981; Sp"alh'olz "-l il, "1985). Initial identification. of enhancer
'and promoter. activitY' in the HPV noncodlng region invol~ed
subclonlng ~ ; fragment from the HPV 16 and .«'18 genome which '
have sequences 'that overlap with the ' Ll 4nd E6 ORFs.
, \
.wherees, the enhancer and .promoter of HPV -11' was initially
localized to _ a relatively small 559 bP. fragment which has its
. : 95 '
upstream border it 7486 (the. L1 stop codon is Ii 7274). The
results ' demonstrated tliat the na fragments ' of ' uPV 11 aJtj 18
.. . . ~ . ) . . .
contam enhancer and promoter function . (see Figure 9. p . 56).
The HPY- 11 ' and 18 . pos:itfve orientation · promoter .Constructs
'. generated significant activity' >elativc to that ·of' the • n~gativC
ori~tation constnicts: indicati~g the-presence .of a functional
by examining the ncr/pAlD-CAT constructs of HPV 11 and 18.
The HPV ;1,6 ncr BamHUAvalI fragment generated ' little or
, \
no enhancer or . promoter activity in 8' 1 cell Jines tested (i.e.
in C33A and SiHa cervical cell lides). .ThiS resulr . is consistent
with previous studies. The majqr S' cap site of HPV 16 EiE7
lr~nstcipts . has be~n m~~ped~ to ". nucl~otide ' 97 "' in . cervical"
carcinoma cells (Smotkin -and~etts te in,l' 1986). ' When: . Cri~. • t1
!I ( 1987) placed' t!te HPV ,16 promoter ,upstream ~r. . the HSVa l
.thymidine kinase (tk) gene, transcripts ' were , generated in both
SiHa and HeLa cells. However, ~hen ' this same , group a8Plined
. :
promo ter
enhanc er
ir / these nc nco d tng : re gion s. T he pre sence of
elements upst rea m of th e promoter was estab lished
.'
theCAT • assay,
lines. ~thOUgh ' the
may be ' d ue to an
'.:.: "
enzym atic
16 enhencerjpromnter
thein
initiation a t the . upstream AUG,
"'!'.•-,
translat ion
of HPV 16 promo,ter aCtivity in ' this study oc~d in
pro mo te r • ,act ivityP97
gene. It is possible -that -HPV
not favored in these systems,~
activity was very " low in both cervical . cell
discrepancy observed ' in Cripe ~ il (1987)
out-of- frame
low level
spite of an in-fra~e E6 ATG pos itioned upstream o~ _ the CAT
<4.1 . ChanderlutloQ or ' · the ca:~i;ltutl.e eahaDctr elementl or '.
/ ' .
"
'.
01>0<_ by Hirochika <l 1I1 ( 1~ with the ' HPV 1
1986;
transcription
occur when
enhancer activity,
contains '.promoter' S
with
enhancer and . the
~onitored . (Kadesh . a?d ' . Berg,
has bee n ~reported' to .
ar~ ins~rted .between an
unit . being
(i.e. TATA :.!,. box) which interfere
distal ' SV4~ promoter, InIu.1J'ition of
sequences
from the
One •possible . explanauon , is thm: ;rn; .region
Ir8nscriplion~ 1 .
promoter sequences
,.:. _.
,
e, Wasylyk -'l - AI. 1983). Another possibility is that there~~~:••.;&:..~..,.",.~~~..•.•.,.,~ ,.,. ;.,'"..•.., ~ '....•...'.'~••...•....•,,_c
o:
.' '.. .. . of '.~
-r- - . ... ~ . ~ _,~ :.. _ . _ ~ . ·~·..~ :.:.:.i;,.*·;;..~,~f;.;...;,•..i.;~~i;;;.' . ;;.~~~"r,:~1·:;;·/
negativereguIa!ory. elements in" ihc ,. .downstream '. portion . of the
noncoding region; removal of these '-' , elements Increases
'enha~ce; activity. In case, of HPV' 16 and 1~. the increase_ in
activity was 10 to ' 2S ' fold with 'rem~)Val of E6 proximal
sequences, whereas the increase in ' HPV 11 was only 2 fold.
"This, slight increase in. HPV 11 enhancer activity may be ~ue
to the ,removal of the TATA box from · the downstream segment
'""'of the ncr fragment. HoweY~r. the : very ';rge increase in HPV
16 and 18 enhancer activity woul~ indicate that a mechanism
such suppression via a negati ve regulatory " element i_,
operating. There two s~ort ~ stretches ~ of ."homoloty found
approximately . 10 bp downstream ofthe enhancer in HPV '16
and "18 (Figure 16). However, " in HPV 11 the - homology. was
largely restricted .to the upstream E2' binding motif,
ACCGN4CGGT (Figure---': 16). Hence, the . . 88 bp fragment .
. (AecI/BtWI) of. HPV 18 along with the analogous HPV . 16 ncr
fragm'nt . may contain sequences that act negative
regulatory elements that function to' negatively ' regulate HPV _
16 and 18 enhancer ,activity. I
Yet another possibility is that decreasing the histance
~tween the ' HPV enh.anC;! and the 5:40 promoter fome~ow
leads to an increase in .activity. A . progressive re~oval . of .~
.proximal- sequences . ~om . tbe.. enhancer fra~ent ' -o~ V 18,
resulted in a progressive increase in activity.' .In a, $:udy by
Swift ~ , Bl (1987); the HPV shown. to
activate the SV40 early promoter . from Kb.
.-
The major \ re~iOns - ot _hamOlgy ' are th.e "9 and 14 bp
eleJ!1ents of \ ,HPV 16 and 18 (underlined). The : BbvI
I
recognitk?n site for HPV 18 , is underlined, . while /the BbvI
.endpoi nt after tse atment with reverse \ transcrlptese is
~~ represented a~ an \Ueri~k (.] , The E 2 binding motifs,
h\'" ACCGN4CGG.T, (degenerate in HPV *,16 and 18) have I been
~; u"d~;lined . The HPV 18 region Is from 7760 '0 7854,
"' ,t • whereas the sequence used for HPV 11 is' from 7816 to 7903.
t
~.
.1\ .
!
i[:
+
\.
' I
• ~ .1
HPV 16
HPV 18
HPV 11
HPV 1S
7780 . 7.790 7800 1810 :. .
~7ACC~:~GTTC~I~7~;~~~;;l~GTA~A~G~~GT- - - --
TCTGTCTACCCTTAACATGAA.CTATAATATGACTAAGCTGTG
: :
CT AGCTGAACATT TTTGTACCCTTAGT ATATT ATGCACA/l.T A
TCACCCT;'GTTCATACATm~ACTGTGTAA,AGGTTAGT ":- - --
7780 77 90 78 00
/ '
782 0 78 30 784 0 7850 1;8 6 0 _
HP V 16 CATACATTGTTCATTTGT AAAACTGC AC1.TGGGTGTGTGC AAACCGATTTTGGGT
, [ " " " , ,, , "J , " ;", ,,'
HPV 18 CAT ACATA GTTTATGCAACCGAAAT AGGTT GGGCAGCACATACTATACT *
. >, : . : : : : ':':. ' . - :. . BeVr :
HPV 1 I CCCACAAAATGAGTAACCTAAG,GTCACACACCTGCA- ---,--ACCGGTTTCGGTTAC
:: : : : :: : : :
HP V 16 CATACATTGTTCATTTGTAAAAC'IlGCACATGGGTGTGTGCAAACCGATTTTGGGTT
7820 783 0 78 4 0 -'850 18 6 0
.'
. -;:
betwee n the
promoter . affects the .efficienCy of
the d istance located
.However, . since ~e " ; HPV' 18 . enhimcer studied by
was -integrated -- into .' the host •chfomosomes,~"J . is
comparable to tbe results . of. the present s~. The current
investiga tion . suggests th~t
.HPV enhancer and SV40
c.
.... .
enhancer . function. Further stu dies such as site direc ted or
~~~";,:~ ~~I~~:.::.~~'
involved the removal of late . region . proximal sequences from
. 'tbe ' .ncncoding region fragments (Figure 17). Thele : upstream '
. 'segments ~ntain (1) : the .':~r~oxycermi~a l port ion of 'the L1 \
t·: · t- ORF ' (except f?~ : .the HPV. 11 _ ~gmentJ. (2) th~ ~T.rich region :
~':'. ' . found in ' all "human genital .papi1lomavirusn~~ing regions, \
~_-..:~) _ p~~ '~~denylatiOn ' signals for the ' late . \ enes, and (4) I
~:; of the ._. E2 binding motif sequences, ' ACCGN4CGGT (Cole
( and Danos; ·1987; Dartmann <I .01 1986: Seed orf <I .01 . 1985). :
< .
'T~e results. show ~hat remova l of this upst ream s~gment
.~onsis.tently de creased the en hancer a ctivity from the . HPV .
noncoding region ' subfragments. In a previous stud~ _~ second
enhancer eleme nt localized t'\ . th~ '. analagous upstr eam
., portion of the HPV .&ic ncr .(8 variaqt _.Qf I;IPV 6 isolated . from
a ve rrucous carcinoma; R,ando {1 a.L 198·6a). However, no
significant , activity W83 ( ' detected when such regions of HPY 16
(6150' to 7463). and HPY 18 . (7119 to: ~S08) . were examined for
I
.'1
~~t; · " :!·" l:.': ':II~:{'~r ~" , .oa~~I '~~~ .
*' .."..18,'.041 11 Ih~1 th~ 'Joc:aIb.ed coDldti.d~·~;~n.
~ . , \ ' " ' . ' .. ,
! . • The diagram ~ep~sents 8 ........... linear rellried,a,n map' . of the '
nencoding . region '~nd the .~unding Ll · . and E6 open :
read ing fra!Des. The constitutive .enhancers of HPV 1~ 1~
and 11 are shown within the bracketS Il as 315" bp, 230 bp,
and 213 bp. Filled boxes show ~e posmons of the E2 motif;
o pe n bokes co rres pon d to degen erat ; ver sions . The
restriction enzymes are: A. Acel;: Av, Avail ; B, BamHI; D,
r
Dralll : H('HphJ; N. Nde,: R, RsaI; S, Saul; Sp, Spht.
"''. .
/
"j
•HPV 18
Ll
,
/
/
I
I
, .
D
a
• Sf
-- ----; -- l-__~__.LN- [21J bp I-S . .. ,.--;:-;'-
- (--.--l~
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enhancer function (Cripe ~ a1, 1987; Swift ,g w. 1987).
This decrease in enhancer activitY. may result . from removal of
upstream . ncr,- sequences. 'n is possible: that the HPY enhancer :;~
is made upar the ~veral modular elem~nts. some of which "'_~
: ;;;"'.are not \ able to function independently as enhancer elements. . .;
.~ this ' situation the upstream _ region, would contain sequences
that funclion . to augment cn1lncer activity only when-placed
upstream of the constitutive enhancer elements. In fact, . two
sequence motifs having complete or almost complete homology
with. the SV40 . cor e sequence, GTGGA.r~. found
upstream" of. th~ HPV . 18 enhancer at ~cre~tide . 7490 and 7350.
Removal 'Of upstream ncr" seqeenees frOJD the ' enhancer of . HPV
18 does not result . in .a -decreaee in enhancer ac tivity when the
enhancer is pla~d in fron t of the homologous (HPV 18)
promoter , (Tab le ' VI, p 78). These ' data sugg est that the
upstream sequences may be important .f~r HPV enhlncer
(but 'not promoter) function~ever, at least for HPV 16 and
18, in~ependent constitutive enhancer elements a re not present
in this region. Gius and his' colleagues (1988) have recently
located an enhancer (IE6) approximately SOO bp upstream of
the'., "E6 cap site of HPV 18, Since ' this enhancer is dependent
upon ' the viral E6, gene product for function, I can p~ict !-~
that at least for HPV 11 and 18
C33A cell s) the enhancer activity
'study is not due to E6-mediated 'act"ivation.
In th e present , study the HPV
(examined in HPV negative
observed in the present
(
18 constitutive '230 bp
6 1). '. Th is
"distance" . effe Qi.
(Table II ,ori e n tati o n -d ep end ent
fragment \ ~nd icates ' that ther~ may be
'phen o menon may be d ue to the surrounding vi~! "" sequences
so m e how causi ng o rie nt.a ti on- de p endent r e gula rt o n of
tr an sc ription al activ ity. Th is orien ta tion-de pe nde nc e may be
explaine d by a distance-rel ated effect.-The . , locat ion of the 230
bp enhancer towards the downstream portjo~ of the inserted
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enh,B~~r sho~ to'~ orientation.ind~p~nd~nt (see also.
Swift . ~ aL "1987). However, the ncr 1.1 Kb (BamHI) ' and. the
837 bp (BamHUAceI) and the 347 bp (SfaN JJAcd ) fragments of
HPV 18 activated the SV40 enhancerless .promoter in an
operating in the l..1 Kb, 837 bp, and 341 bp fragments but not
th e 230 bp enha nc e r fr agment (see diagram below)"
'Puthermore, the central Positioning of the 213 b~ constitutive
enhancer, in the 559 bp HPV 11 ncr fragment seems to have
all owed ori ent ation-ind ep end en t act ivity witholl t int e rferenc e
from any distance-related '. parameters. It is, therefore, probable .
that the . length , of the vira l sequence between ·~he HPV .
enhancer and the SV40
orient ati on independence
,
favored when examining
promoter may be able to influence
of the enhancer. This possibility is
the diagram J,shown . below with the
constituti ve enhancer of ~PV 111&~ represented by ({#]I["'D
a';'d the surrounding viral sequences indicated by
line (-)-.
the dolled
559 bp ~-I######l- YES
I
213 bp 1######) -,
.,
f' HPV 18
1.1 Kb ·~--·-~-I····· :·l--- NO
.837 bp _._...__.._ (.......) NO
347 bp
··- 1·.. ····) NO
230 bp r·····..) YES
The results presented in Table V (P. 78)' indicate that .;..the
HP V 18 347 bp enhancer funct ion when located
downstr eam from the CAT gene. However, 'the level of
enhancer activity was less than in the constructs In which the
347 bp enhancer frainent was placed . upstream' 10 the CAT
gene. The SV40 340 bp enhancer and promoter region [ra&l?~nt
(PvuIlJHindIlI; Figure 2, p 27) was 'also placed downstream 'of
the CAT gene in ' an aueml l~ p;oduce an internal contror
for this exper imen,t The ability. of- the. SV40 ' enhancer to
stimul ate CAT act ivity was drastically redu ced (by great er .
than 60 fold) 'when placed ' downstream from the - gene (Table'
. V, P 78). Earlier studies have reponed the' ability of the SV40
:" ' , ~
activate " p l asmj~ pBR3 22
IlL 1981; W"'Ylyk <l '1lI,
: 1~83) . This eff ect to "enhancer damping"
(Kadesh . and ' Berg, 1786; Wasylyk, 1983). The decrease observed
18 "enhancer fragme nt was placedin" activity when" the
.
downstrea m from the
HPV
gene may also be due to "enhancer
d~mping". Alternatively, this decrease in activity may be due
to the larger distance · between the enhancer and the upstream
promoter increasing as the enh~ncer is placed downstream. In
fact, the constructs with the enhancer placed . nearest to the
.downstream ' portion of" ,t hr . gene (pT-52) do vseem to generat e
the highest enzymatic CAT acti~ty,
. ' "!
4.3 Upstream enhancer ) seque nces are r~qU)"'d
for HPV 18 promoter 'fun~iIO~ ! ..
l;lnldir ectionaHy
; ,
By definiti,on,.
upstream of "~~-nd
I
promoter sequences are required imtnedlately
,
in the same orientation as the linked gene,
while enhancers act ivate tran scri pt ion in orte nta tton-
in~e.pendent manner.The 1.1 Kb (BamHI) fragment of HPV 18
was shown to function active promoter when placed in
the same orientation j"as - that of the linked gene (p29), The
minimal sequences reqf ired for HPV 18 promoter - function were
localized to , the 4~ i . bp '(BssHI}4JamHl) downstrea~ -portion o f
the 1.1 ' Kb ncr fra'gment (pT·29). The CAT activity generated
by" both HPV . '18 !promoter constructs,. p29 and pT·29, were
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identical, suggesting that reg io"ns . upstrea m of the Bu HII .
(7572) site not requir ed for transcription from the.
homologous HPV 18 prom oter. T o idcn!ify th e smallest
sequence required £o:r promoter function, the BssHIVAccI 164
bp enhancer fragment was inserted in the opposite orientation"
relative to that of the downstream promoter sequences I (210
bp) to generate pT-28 (Figure 7, p 44). The ' CAT ' activity of
this construct (pT.28) was negligible (close to that of the
negative control) suggesting that some or all of the upstream
164 bp e nhancer seq uences required in the positive
heterologous promot~r even ln the negative orie ntation (Ta~le
VI, p SO) nu; indicated that the promoter sequences. overlap
with the enhancer sequences.
A recent investigation has also localized . th e .HP V 18
.
promote r/en han cer function to a 400 . bp fragmen t co mprising
the earfy . region proximal porti on of the ncr (Thierry and '
Yaniv, 1987). When this same group don7d the" E6 proximal
240 bp promoter fragment (RsaIJB~mHI) of ~V 18 <figure 17,
101) downstre am of the SV40 enha ncer they obtained
activated by 8 heterologous, enh8nce~. It is possible that the
240 bp downstream segment of '
..~-~ .
activity. Th is suggests that the
th~ HPV . 18 ncr is suffici;nt to act a promoeer". when
.~ ~. ' ,. ~ .' '.'~.' ;.'" .'. ..; ~. - \ ..
: ,'1
1\18 "'
extra 28 "bp RsaUAcd (7138 to : 7766) "Included . 'l> ,lbe" ~ : bp
promoter trapnl (RsaJIBsmHI; see F1gure 17, ~ 101) conia;in
importan t sequences required for . promoter function; this 28 bp
region . is absent ' "from- the 210 bp (AcctIBamHI; see" Fi~ 17,
P 101) promoter fragment used in this study. _ Therefore, the
~- HPV /8 . promo!cr did
requirement of this extni
not function, perhaps due ':0 the
28 bp upstream' of and in the same
o rienta tion as the 210 bp AccllBamHI promote r fragme nt.
Anoth er poss ibility is that th e SV40 (he terologous) enh ancer
used by Thierry and Yaniv. (1987) does not require promoter
sequences upstream of this Rsai (7738) site. However, it is
~Ie that activation by the homologous HPV 18 enhancer
requires promoter sequences from . the enhancer region ( in ~he
same orientation) to enable promoter function.
4.4 Cell type. spedfic:ity ' and sequen~
16.. 18, aDd 11 cubaooen
relatedness DPV
. ~ mentio.ed earlier, HPV types 16 and 18 associ ated
~ith . cervical neoplasia , whereas 1-!PV 1J has been largely
isolated from papillomas of the head and neck region and also
from be nign lesions ~r the ex ternal ' genitalia . It was ' oc'
interest to determine whether the pathology of the lesion
the tissue tropis~ of ' .the · infecting . vi~ might be relaied to.
the re g,\ latory elem en ts (e nhancers/prom oters) which cc n trc l
ea rly gene expression. The identificati9n of duplications in the
"'
highly aggressive lesions would see~ to support this
possibility. These variants were isolated Ijom a nasal inverting
papilloma' (HPV 11r; Respler l:1 B1 1987), from a highly
a&8!essive verrucous carcinoma {HPV 6vc, Rando ~ aI.' 19a'&),'
and from a ~uschke.Lowenslein tumor (HPV 6d, Boshart . and
zur Hausen , 1986). These duplications resulted in' a much
hlgber expression of · the CAT gene driven by the regulatory
regions ,from the v8ri~nts ~v llr and HPV 6v~ (Pater ~ ilL
1988; Rando ~ aI. 1987a).,·" Additional ,enh8yer elements may _
be adv,an~a~eous for the. expression of specific early viral
genes and could possibly contribute to the aggressiveness of
the lesion or to its carcinoge~ic , progression. Further, 8, recent
repo~t by Byrne -'.1: al (1987) indicates jbat n,talignant
conv ersion of lung papillomatous lesions and subsequent
metastasis Ieto lymph .nodes involves the duplication of the
HPV 11 Thus it appears that changes in .oncogenicity
might be correlated with changes in the regulatory elements
, affecting gene expression. One goal, of the present study has "-
been to determine whether th: tissue tropism exhibited b1 the
genital HPVs ,may be associated with the (sequence and
functional) relatedness of the regulatory elements of the I 1
prototype genital HPVs (16, 18, and 11).
I ,searched .for hom?logy among the enhancer sequences' of
these viruses. Sirite HPV 16 and 18 are ,oncogenic. and show
somewhat similar tissue tropism, while HPV 11 is nononcogenre
"HPY , 16whcthertrop~m, ' I .askedtissuediffcrcnt
. ' . -,
artd 18- sbere a common Sequence in thcir regulatory - rcgi0!l'
which is differcnt in HPV 11. Comparative , ana'YJis of thc
sequences of HPV ttf and .18 revealed' a 60 bp rcgion near thc
dc wns tre em end of the , e n ha n cc r fr agment having
appr~m~te1y 83 % homology (Figure 1~ see also SWift m 11
1987). ~etween , the oncogeni c HPV 16 and 18 and ~e
nononcogenic HPV 11 the only homology was a 11 bp stretch,
ATITITGGCfT,' foun d ' within th is 60 bp sequence (
Ftgures 19 and 20; for HPV 18 the sequence
AITITAGTITG).. This ' 11 bp sequence is also found in HPV 6b
(Schwarz~ d. .a.L 1983)" a!'d with a single . change in HPV 33
(Cole and .Streeck, 1986), where as ~even of the 11' bp,
TITITGG, are also found 'in the' noncoding region of B~V 1.
Cripe d ~ \ 1987) .ha~ also. locali,zed the enhanc~r of ' HPV 16
to 224 bp which includes the ~bb.reviated oeta mer I motif ,
TITGGCIT. · These authors note that the 'presence of this
cctamer motif ' in all sequenced genita l HPVs and postulate
that the kera t fnocyte-dep e nden t e xpressi on . o f g e ni~ a l
papil lomavirue se " may be attr ibuted 10 this sequence . Indeed,
the inverted consensus sequence, AAPuCCAAA, is found In the
vacin.lty of the TATA box of severa l bovine, huma n, and
mur ine epiderm al cytokerat tn genes and of th e hum a n
invoJuc:rU:t gene (Blessing d 11 19~).
This sequence alone does · not appear 10 regulate tissue
trop ism. Eight or nine of . the 11 bp , are found i1l the
I(
The region found between the brackets U IS a S9 bp stretch
of 83 % homology between HPV ' -16 and ' 18. The ~V·specific ."
r . • •
element of HPV l~ AlTnTGGCIT, is underlined as is the
closely related sequence foul)d, in HPV 18 (AJT1TAGTITG).
The ~230 bp region of the HPV 18 enhancer has been
indicated by ' the p~esencc: of two RsaI sites ' at 7508 and
1738:. The enhancer regio~ of HPV 16 and 18, is preceded by
the E2 binding' motif (underlined).
\
18. Npcleo~de JlUgnment of ' the
enhancer region&.
HPV i i6
I
..
" 4 5 0 7460 7470 7 480 1 49 0 7 50 0
CAACCGAATTCGGTTG CATGCTTT TTGGCACAAAAT GTGTT TTT TTAAATAG TT CTAT GT
: : : :.: : : : : ::: ': : : : : :: : : :: : : : : : :
CAACCGATTTCGG'l"I'G CC:"- --TTTGGCTT ATGT CTGTGGTTT TCTGCACAATA CAGT1t.C
. ' 4 6 0 7470 7480 74 9 0 75'00 - .-
RsaI
1510 . 7520 7530 7 540 7550 756 0--
CAGCAACTATGGT'PTAAACTTGTACGTTTCCTGCTTGCCATGCGTGCCAAATCCCTGTTT
GCT~GCACTATTGCAAAATTTAATCTTTTGGGC';CTGCT- - - -- -_--- --- :- -CCTACA~
• 7520 1 530 7540 755 0
75 1 0 , . 7580 , 759 0 760 0 7610 762 0
~CC;qACCTGCA~T~7~~~AACCAT.T~CAr;G;TT'I'TTA;~;TGCACT~;~TG;~Ac; ..
AT~;AACAA~;~gGCGCCT~~GGCGCA~;~~AGGCGC~~g~~GTAT'l~~~gATTT
7 6 30 " 7640- 1650 7660 * 76 70 7680
~~:rcAA~;~CTATGTl-C~TTGTGTCATA;AAA~;~~A;CAC;ATG;G;;AACGCCTTAC~
TCCTGTCQ.GGTGCGCTACA1\CAATTGCTTGCATAACTATATCCACTCCCT AAGTAATAA
I 762~ , 7630 764 0 7650 7660 7!i70
7690 _ 770 0 "71 10 77 20 773 0' , 77 40
TACCGCTG'1'TAGGCACATATTTTTGGCTT GTTTTAACTAA CCTAATTG CATATTTGGCAT
[ " s e- " " " ' '' '' '' '' ' r- ' ' ','' ' " t r t t tt t r r r t ' " '' ' J
AACTGCTTTTAGGCACATATTTTAGTTTG TTT TTACTTAAGGTAATTGCATACTTGG CTT
768 0 , 7-690 77 00 71 .10 7720 71 30
. .
7750 7760 777 0
AAGGTTTAAACTTCTAAGGCCAACTAAATGT
GTACAACT~C~~ATGTCCAACATTCTG
' R~~; 4, O . 77 5,0 ",7760
' "' K< : ' ~. ' -, ~ :. ; .., :
The E2 ,binding motif. ACCGN4CGGT. is underlined, is the
HPV-specific motif. ATITlTGGCIT.
. ~:;';,l, 1' . . NUcitoCld.e. alipmeDt:J 16 and II. eDbaD~r ' aeQueuca .
..,r-
,
.
,.
760 0 76 10 762 0 76 3 0 7640
CAACCGTTTTCGGTTGCCCTTACATACACTTACCTCAAATT TGTTATAACGTGT---- - -
: :: :
CAACCGAATTCGGTTGCATGCTTTTTGGCACAAAATGTGTTTTTTTAAATAGTTCTATGT
7 4 50 ! .7460 747 0 7480 7490 . 750L
7 6 50 . 76 60 767 0 7680 ..
--- - - - ------TTTGTACTAATCCCATATGTTGTGTGCCAAGGTACATATTCCeCTGce
eAGCAACTATGGTTTAAACTTGTACGTTTC~TGCTTaCCATGC~~G~CA~A~~~~TGTTT
1510 152 0 • 1 5 30 754 0 155 0 1 5 6 0
7100 7110 712 0 7130 7140
AAGTATCTTGCCAACAACACACCTGGCCAGGCCGCGGTATTGCATGACTAATGTACAATA
TCC~GA~C~~ACTGCTTG~CAACCATTCC"TT~TTT~·~ACAC;~CACT~~~~G~~T
7 510 1S80 1 59 0 76 00 . 16 '10 1620
7760 1170 . 7780 · ' 71 9 0 78 0 0
AACCTGTCGGTTTGTACAATGTTGTGGATTGC1r.GCC1r.1r.AGGTTA1r.AAGC---- - - -- - --
: : : : :::':: : ::: : : :
AC;~~~TCACTA;~~~CATTGT~I'i~TATAAA~~~~1r.TCACT~~~GCCAAC~~~~TACA
1810 . 7820 7830
---.- ~------ - --· ---ATTTTTGGCTTCTAGCTGAACATTTTTGTACCCTTAGTATAT
: : : : : : 1: : : :
TACCGCTGTTAGGCACATATTTTTGGCTTG----------TTTTAACTAACCTAATTGCA
1690, 1100 111 0 1120 71 ) 0
,850 7860
TATqCACAATACCCACAAA1r.TGAGTAAC .
T~TTGGCATAAGGTTT;.AACTTCTAAG9CCAACTAAATG'l'
1740 _1150 . '17 6 0 7-1·10
•.,..
\
The E2 binding motif, ' ACCGN4CGGT, is underlined as is the
HPV- specific ele me nt, ATTTTTGGCTT . Thi s motif ' is
represented by AlTITAGlTTG in HPV 18.
Figure'. 20. Alignment or tb.t
~
KqutnC't. :
11 and ' 18 enbeaeer
... .. .., ,
HPV 11
VERSUS
HPV 18
760 0 7610
CAACCGTTTTCGGTTGCCCTTACATA---------- - - ---- - - ------r------ -:.. -
:: : : : : :::: :: : : : :: ::
CAACCGAT'l'TCGGTTGCCTTTGGCTTATGTCTGTGGTTTTCTGCACAATACAGTA'CGCTG
7460 , 74 70 1480 7490 7500 -nl0
I. RsaI
. 7620 ' 7630' . 764 0 . 7650---
-C ACTTACCTCAAATTTGTTA TAACGTGT-- - . TTTGTACTAATCCCAT A I
Gh~~~ATTGCA~~~~~1..\~~;Tt~G~CAC~CTCCTACATA~~~TG~~C~~'~GOCGC
7520 ' 7 530 75 40 ' ~S~ O .. 7 560 7570
7670 7680 7690 " 7700 7710
TGTTGTGTGCCAAGGTACATATTCCCCTGCCAAGTATCTTGCCAACAACACACCTGGCCl\
GC~C~~~G~GCATATA~~~CG~A~~~~GT~TTAG~~A~~TCCTGT~CAGG;bC~~T~
7580 7590 . 7600 1610 7620 7630
7730 7~ 40 " 775 0 7760
GGCCGCGGTATTGCATGAC.TAATGTAC--------- -AATAAACCTGTCGGTTTGTACAA
CAACAATTGCTTGCATAACTATATCCAlZTCCCtAAGTAATAAAACTGCTTTTAGGCACAT
76 40' 7650 7660 : 767 0 1680 7690. .-
7780 7790 ~ 780 7810 7820
. TGTTGTGGATTGCAGCCAAAGGT-TAAAAGCA TGGCTTCTAGCTGAACATTTTT,GT
: : : . -: ' :
__ ______________: AT TTAGTTTGTTTTTACTTAAGCTAATT
f ~ 77 10 772-0
78 30 1840 1850 7860 '"
ACCCTTAGTATAT~ATGCACAlIT~CCCACAAAATGAGT...AC
: . : : : : - i :
GCATACTTGGCTT~MCTACTTTCATGTCCA~.CATTCTG
. 7730 , ', 774 0 . 7750 1760 '
Rsa I
, : ~",Jr.!:r'
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regulatory and I~tc regions of . the papovavirus, ' BKwiuch has
· a different .tropism .than that of I papillomavirus (Sen ~ w.
1979). This~ 11 bp sequen~ rs also found ' in pBR322 (~litcliffe.
1979). J wift £1 111 (1987) observed two . functional domains -in
the enhan cer regions of HPV 18 bOth ha.ving full enhan cer
.activity in HeU cells. However, ' only .on~ of the domains
contains the 11 bp seque nce. -
As mentioned above, the HPV 1~ 18, and tr--Eii"hancer
activity exhibited cell-type specificity (fable < Ill, ~ 70; Figure
· 1'3, P 72). The HPV 1. enhance r had consistent ly high~t.i
activity and appeared to be · active in a wide~ range of cell
~cs~ t~an th; ' HPV 16 lind 18 , enhancers (see Table III, p 70;
Figure 13; p 72). .Thi~, is probably due to transcriptional
oontf';Jl which is less stringent in HPV 11 than in HPV 16 and
· 18. The high level ~f . vari ability obse rved betwe en the .
sequences of the HPV 11 enhancer and the HPV 16 and 18
enhancers may be associated with the observed differences in
cell-type specificities and enhancer stre ngth (Figures 13, p 12;
Figures 19 and 20).-...Recently Chow ~ ill (1981c) located the
enhancer region of HPV 11 to a 140 bp sequence (1730 to
7870). Interestin~y. sequences resembling the GT, Sph, a~ P
motifs (Zenke ~ ill. 1986) and the recognition sequence for
'-..--cTF' (NF-l) •were- found in , the HPV- 11 enhancer (Chow tl, _~
1987c; ; Hitochik8. ~ ill. 1988). Comparison of . these sequences
in HPV 11 (i.e:-. , their presence . and their position) with the
HP V 16 and 18 enha ncer sequences reveals no significant
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, homology.1) .The presence or absence of these various motifs in
8 .specifi~ . pattern ~ay . allow' - expression ' of the HPV . ·11
enhan~r in a wider range of cell types.
HPV 16 and ~8 are generayy restricted to one J>8!ticular
type of lesion in the geni tal area , while HPV 11 shows
pathology distinct from that of HPV \ 16 and 18 in the genital
area and is also unique in its ability to grow in the upper
""respi ratory trac t. Investigation of HPv. 16 and 18 enhancers
indicated that, the activity is genera lly restricted to human
epit helial cells' derived from cervical carcinomas (Table III, p
70; Figure ' 13, p 72; sec also Cripe ~ ill. 1987; Swift t1 ill.
1987; Thieny g .ll1, 198!b). However, the relative strengths of
the HPV 16 .and 18 enhancers' vary depending upon cell type
(Figure 13, p 72). This means that even though the early I
region proximal .segment of the HPV 16 and 18 ners share
significant homology (see Figure &, p 53), other enhancer
elements present in the upstream segment of both HPV 16 and
18 could contrib ute to. th e differential activity of these
Computer alignment programs were used in -this
study to identify HPV sequences having homology with
number of consensus sequences; t~ese seque nces are shared
among different . sets ' of enhancers. The HPV 16 & enhancer (7450
to 7'178). contains sCJquences resembling the SV40 . "core"
element, GTG~, the Sph I motif (AAGCATGCA) and
the ..r~c~gnition sequence for API (TGACfCA; TPA·responsive
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clement) and IGNFA (ATITGCAl) faeto.1'l (Filurc 21; ,. Angel n.-
iL 1987; Lee ~ ilL 19878.0 1987b; Sen and BaltiIilo;e, 1986;
:ienkc ~ a1. ' 1986). This region also has sequences similar to
d ements found in the polyoma .A-2 (T~CCCA) . and polyoma
alpha (GT CAGTTA) enhanc ers . In con trast, .the HPV 18
enhancer was found contain sequences that resemble the p .
(TCA~1rAGTCA) an d TC (TC CCCAT) motifs and the
recognition sequence for AP3 (TGTGGTIG) (Figure 22; Zenk e
g i!1 1986; l ohnson l:.1 §1 1987). Sequences similar to elemen!'
found within the SV40 and HPRT enha ncers (CCAGOCfCCi
Melton l:.1 W. 19S4) and to the recognition sequence for the
fgNFA factor (Sen ' and Baltimo re, 1986) . were also present in
the HPV 18 enha ncer. However, there were no sir;nilarities
betwee n • the HPV 16 and 18 enhancer motifs as _'revealed by
this study except for the IgNFA recognition sequ ence which is
found within the 60 bp region of the HPV 16 and 18
en hancqs. Recent investigations have indica ted that multipte ,
copies . of the GT· or Sph- . motifs function as enhancers
with celf-rype specificity (Ondek £t ~ 1987; Schirm '" D1.
1987). ' Resull s from the se studies along with the present
'.;
.. .~
·"i
.....,' ~,,: .>'~.' ,~ ..: :& '" .:,--, ~" , , .:.. 0''<J' ;; '.,.... ,••• ~ , ::':~;:'c~\,:; .~, . ~ . ~ ;t.~i ~~ .~ i., '-- '
. !
, I
investigat i on ind i c a te th a t e n ha nc e rs of differing , ~
specificities/activities can' be assemb led from many ind ividual
seq ue nce motifs by combining them , in diffe rent patt erns '.
(Schirm C1 B1 1987). The sequence relatedness 't>etween ' the
HPV 16 and 18 ~nhanCers do It:em to correlate .with the
observed epithelia l .sp~cifi~ity . Howe ver , . the . differential ce ll-
\
· eaballctr sbowlng
The - APt and IgNFA recagnition, sequences homologoUS:
10 th~ HPV . 16- enhancer. Seque nces . similar to the. · Sph motif
and ·core· element of SV40 and to the polyoma alpha and
A-2 elements are . indiciued. The E2 binding motif and HPV-
-specific elements of HPV t6 are unde rlined.
·1
I
·.,.r
HPV 16
VERSUS
ENHANC ER EL EMENTS
GTCA
745 0 7460 7410 7 460 74 90 7500
ACCGAATTCGGTT GCATGCTT TTTGGCACAAAATGTGTTTTTTTAAATA GTTCTAT GTCA
AAGCATGCA
E2-bindlng Sph
motif motif
7 5 10 7 52 0 753 0 75 '40 7 5 50 , 7560
GC1I.ACTATGGTTTlIAACTT GTACGTTTCCTGCTTGCCATGCGTGCCAAATCCCTGTTTTC
GTTA
po lyoma
alpha
element
7570 7Sa O 7590 HOO 7610 7620
CTGACCTGCACT GCTTGCCAACCATT CCATT GTTTTTTACACTGCACT ATGt GCAACTAC
/ '
TCCAc e CA
po lyoma
A-2
element
~~~~TCACTAT~;:gATTGT~~~~ATA1I.AA;:~~TCACTA~~gceAACG~~~~ACATA
TGACTC A . ! '
API.
recognltion
sequence \
7690 71 0 0 \ 71 10 1 12 0 7130 1 740
CCGCT GTTAGGCACATATT TTTGGCTTGTTT TAACT AACCTAATTGCAT ATTTGGCATAA
715 0 , 71 6 0 7710
GGTTTAAACTTCTAAGGCCAACTAAATGTC;
flPV- speclfic
mo~if
GTGGATTG
"vvc o r e"
e lement
AT'I'TGCAT
I g HFA
reccen 1tion
s eq uen c e
HPV 18 enhaacer ' Ih~wlnl
- The AP3 and IgNFA recognition sequences are similar to
motifs found in the HPV 18 en~anCer. Iri addition, sequences
similar to the PC and TC motifs of SV40 and the
.CC~GGCTCC motif of SV40 a nd c f the hypoxanth ine
phcsp bc ri bosylt ransfe ra se ( HPRP "ge nes
underneath the HPV 18 enhancer sequence.
di spl aye d
The" E2 binding
motif a nd th e HPY· spe cific el e ment of HPV 18 are
underlined.
\l ERSUS
ENHANCER ELEMENT S
7460 74 70 7480 7490 15 00 7~1 0
ACCGATTTCGGTTGCCTTTGGCTTATGTCTGTGGTTTTCTGCACAATACAGTACGCTGGC
E2-binding TGTGGTTTG Rs al
motif ' AP 3
recognition
sequence
7520 75 30 7540 1550 756 0 757 0
ACTATTGCAAAATTTAATCTTTTGGGCACTGCTCCTlICATATTTTGAACAATTGGCGCGC
7580 759 0 \ 76 0 0: 7610 762 0 7630
CTCTTTGGCGCATAT AAGGCGCACCTGGT ATTAGTCATTTTCCTGT CClIGGTGCGCTACA
TC',.~~~~~~~ CClIGGCTCC
P moti f .iI'" SV4 0/HPRT
~ . e l ement!
7640 76 5 0 7 6.6 0 . 7670 1 680 7 690
ACAATTGCTTGC~TAACTATATCC"'C;~;~T~AGT"'lITAAAACTGCT'I"l'TAGGClICATM
TCCCCAT
TC motif
7ioo 77 10 77 20 7730 7740
~TTTTTACTTAAGCTAATTGCATACTTG.GC;TTGTAC '\,
HPV-spec ific
7 motif
. ':t'
ATTTGCAT
I gMA
recognition
sequence
.;
I '
cervical .cell.. Unes could be associated with the presen ce . of
differe~t ~otib in the c;F ancer regions .or these viruses.
,
4.5 Tran s·ngulatioll by' the HPV 16 E2 geDe product
As stated eeslt e r, gene ' e x pressio n by many ~ iruss.s is
controlled llOt only by c is-acting clem ents, but also in ...trans
1?Y the 'gene products of the ' virus. Results from fhe
present study demonstrate that th~ HPV 16, 18, and 11
enh ancers trans-activated by th .; . HPV 16 E2 gene product,
, T his is In agreement t. w ith previous observat ions that trans-
a ctivation ' by the E2 gene product .o~ either ' HPV 16 (Cripe ', .tl
BL 1987; Phelps and Howley, 1987), ' HPV I, HP\t II , HPV 18
(Hi rochika ~ . ll1. 1987), or BPV 1 (Spalholz. ~ W. 1985, 1987)
W8~ required to detect HPV e nhancer functio n in CV-l and
. , cervi cal carcinoma ce lls (Cripe !21 Bl. 1987; Thi~rry and Yaniv,
1987). CV·! eel" chosen for th.e present studies because
the constitutive ' activity o f. the HPV enha ncers is ~e,tat ively
low in this cell line. The level of activation seems to . be
gr eater • for th e HPV 11 and HP V 16 enhan~rs ' compared to
th at of 'HPV • 18 (Figurc 14, p 82), . Thi s is consiste n t · with the
trend obselVcd . by Hfrochika ~ Il (1987) who observed that
the E2 .gene pr~ucts or HPV 1. HrV 11,. and BPY 1 acti vate
the' HPV 18 enhancer to a smaU CX!~nt or, not at a ll in CV·l
cell s end that the HPV 11 E2 sene product stimulates both
enhancer regions of peplllomawuses contain mu ltiple C!Jpie..s ...of
the palindrome, ACCGN4CGGT. which has heen .shown to .be
required for E2 trans -activatio n and for ~ protein b~~ing , in
•
~ . (An drophy .c1 ilL 1987; Hauge n ,sa iL 1987; Hirochika .c.l
.!l1 1988; Moskaluk and Basta, 1987; SpalhoIz g aI., 1981),
Compariso n of the HPV noncodi ng re gion sequence indicat es.
the ~resence of three of these motifs ' in HPV 16 and 11/8
wher eas there are fou r , ~5 'in HPV 11. The fo~rth copy
found in HPV 11, immediately down~t:eam fr om the enhancer,
has been replaced !n: . the HPV. 16 and' 18 nonco ding ~ re gion
wit h degenerate . ve r sions (see Figure 16, p' " 9'8). R ecent
evid~nce \ suggests that the degene rate version ,. presem' in tIPV '
16. AcCGNSCGGT, is not a target for E2 ' binding (ifuochik~ .c.l..
.i!1. l~ th is 'is due to the stringent re(.u"re~ent ·' Of "' 6"
- f\. nucleotides (ins tead of 7) between th e two halves of the
palindrome, ACC and GGT. for in Yi1I2 binding to occur. The
.,re p ort ' b y H irochika ' ~ ill (1988) a lso su~gests - that . the
sequence of these six central n ucleotides m ay influence the
strength of association with • the E2 p.rote in. !h~, ' the HPV 18
degenerate motif, ACC GN,.AG GT. p robably ' has a IOwe·r' ".affinity
tha n the ACCGN4CGGT ' mo tifs. Positions of the other " three
moti fs, one upst ream of the , enhancer and the other .
repea ts be~n the CAAT·1ike box apd TAT~ box
promoter, eonsc:rved a mong ' the three' ~ral , types:
the fOUT centra l nucleo tides . of the E2 bindin~ ~otifs . of H~V
/
2) of the E2 motifmUltiple Copies ('>i nott",
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16. 18, and 11 are compared , patterns. that may, explain ' _.th e-.
hi~ E2 gene p~uct activation of HPV 16 and - 11 re lative ' to'
1.hat of HPV 18 were not f~und. . In fact, the -binding ' motifs of
~V 11 and 18 are slight~ more ;>imilar than th ose of HPV 16
to 11. This suggests that activation of the HPV enhancer
by the E2 ge~e product involves O?orc tha~ the interaction of
the E2 prot ein with ' the ACCGN4CGGT motif. It is ' possiblf
that the 'Sequen~ of th~ nucteo t ldes immediately ' outside of
and/or . the dis tan ce between the various E2 motifs may
influence . th e affin!ly of E2 protein ' binding and . subsequently
E2~mcdjaled trans-e crfvatlon,
While resul ts of the current_ study -s~~w that the presenc~
of ."o~1y one E2 binding · motif . in addition 10 viral .enhllncer .
p ' .sequ e nces is su fficient for trans-activation , whereas the E2-
depend~nt activatio n of rrenscrtpnon > from the BfV I ncr has
been reponed to require at least (but . preferably • two)
motifs at each end, of the e lement (Spa!holz ~ ill. 1987). This
s~ggcSts t ha t som e coope ration between the two ends is
"in the activatio n mechanism. It IS possib le that th e
higher level of activation observed with the ncr plasmids (p6•
. p7. and pS) ' may ' be due to ~ion " among . the th ree (o r
four in" HPV I}) E2 binding motifs . Indeed, insertion ·" of one '
copy of "t he ACCGN4CGGT . motif (without viral enhancer
s,~quences) " upstream ,of. the SV40 .p romoter wes' insufficient to
confe r E2-dep,en dent actlvatt on . S ig~'ric ant activation does
present (itirochiia ~ 11. contimmg . one . o r . '
multi p le E2 bi n ding moliC(s ) . alo ng with v iral ' ~nbancer
sequences ar e activated _ by the El geoe product.. These res~ts I
sugge s t tha t · t h is' ~2-dependent t u ns-regulat ion m ay . be
influenced by the, constitutive enhancer . Indeed, recent reports
indicat e that one copy of the E2 bindi~g site bas E2-
dependent enhancer activity only when it is in the prese nce of
Ihe . constitutive enhancer (Hirochika ~ B1 1988). .The presen t ·
investigation and otbers, (Cripe -'l .w. 1987; ,HiroChi~ .tl a.L
1988) show that the constitutive enh ancer alone is insufficie ni
to , confer Bz-dependent activation . Collective ly; the results
sugges t that the . differell iial E2·de pend cnt · activation of th e .
HPV ·16, 18, and 11 regulatory regions ~ay involve .cooperative · ·
inte raction of t he E2 b inding p.ro tei n(s) with othe~ \'
I~criplional factors
~nstitutive enh ancer.
which bind to elements present in ' the
i-
T."t"~~.. ;:-.
The result s show tha i the E2 gene produ~ · can trans-
activate when the promoter is hete rologous (i.e. SV4Q early
promoter) but not homologous (i e. HP V promoten ). This ' could
be du e -10 · repression of homologous promoters by the 8 2
product. The re ' is evidence from studies' by othen ~o · su~
this. For instance , Lambert ~ III (1987) have , identified
repressor ' function to the carboxyterminal portion of the , BPV
1 E2 · P exp r essing plasmid. Furthermore, Thierry and , ya niv
(1987) have reported the repression • of tr anscription from the
HPV 18 PIOS promoter by cotransfC?ctiog with ' 8 BPV· I E2
. ' .. ' ...
expressing, plasmid: The same BPV 1 E2 expressing plasmid
found . tc trans-aeuvate expression from the DPV 1 PS9
promoter and from the enhancer of HPV 18 placed upstream of .
the _SV40 promoter (Spalholz ~ . .aL 1987; Thierry- and , Yaniv,
1987). is d'ifficult from ' the present study to pinpoint
repressor functi on to the E2 gene 'product due to the low
constitutive enhancer activity in Cv-I cells. The resufe s
certainly support the differentia] function of HPV 16 E2 gene
product when HPV 16! IS. and 11 .enhancers "expresse d
from homoJogous promoters opposed to heterologous
promote~. Com~tive 8mily,is of the sequences upstream : the
BPV I E6 ORF with those of the genital: HPVs 'revea led" that
in BPY1 'th e ~ binding motifs f are found greater , than 130 bp
upstream of the major promoter (i.e.E6 promoter; Figure 23).
On the contrary, in HP'y 16, 18" and 1) two E2 binding 'sites
are ' present between the TATA and CAAT-lik e cons ensus
. sequences that preced e the major s tart sire for the early
transcripts of these viroses (see Figure 23; Pater • .tl m. 1988;
Thierry ..tl ilL 1987b; Smotkin and Wettstein, ' 1986). . As
speculated by Thierry and Yabiv . (1987); , the binding of
multiple E2 protein mol ecules might sterically interfere· with
. the formation pf an active , tninscriptiQJlal complex. It is not
y~~ .known which C?f the E2 gen e products (full length ' .or the .
Oterminal. products) are r~sponsible for thi s repression. ~th "
the full length and the C~terminal E2 products of BPV .1, .f\pY ·,
16, and HPV J1 have been shown to require E2 , binding ~otifs
Figure 23. General oriaalzaUon ~r ' the' . paplUomavIrUJ control
.
region.
The dotted lines repres ent sequences missing from particular
viruses. The pote ntial ATG for .the, E6 ORF is represented
by the arrow. Th e lett ers T .and Aff indicate the positions
of TATA... ' boxes and Aff rich region s, resp ectively; the
I eAAT -like boxes are . represented by" the lett e r C. Filled
boxes show " the
/,, 'boxes corresp ond
positions of the \ E2 bindi~g motifs; open
to ..degenerate versions. The sequences for
BPV 1 (Chen <1 a!. 1982), HPV 8 [Fuchs <l l!1 1986), HPV
6b (Schwarz ~ ilL- 1983), HPV - 11 A rtmann .t1 al. .1986) " and
HPV · 33 (Cote a nd Stre ck,; 1987); ~ 18 (Cole and Danos,
1987> and HPV 16 (Seedorf ,g i1 1985~ were obtained from
previous reports.
!
.:: .• ' i j
7402
L..c./
I
,·__1_1 ...lIUIL . ' . r>E6
.
J
7363 7620 - - -<--'---c--+-1 8PV '
. .,
', " v ,, :" "" i ,"",:, "
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for . their action. . Thus, it is possible that DNA binding by th e
intact and!or th e C-term inal E2 gene products "sufficient ,;"
"10 repress HPV expression by stertc hindrance.
4.6 Transoreprt ssion by the HPV 16 E7 gene product
.
The E7 ORF of HPV 16 encodes a trans-regulating product
which was found ' 10 repress tran s-activati o n mediated by the
E2 gene product (Figure 14, p . 82:, Table VII , p 86). Wh ile it is
difficult from th is present study . to determine the ex act
mechanism of tr ans-repression by ' the E7 gene produ ct, the
repression of pSV2· CAT by the E7 gene product -(see Table IX,
p 89) ' suggests that repression by Ihis gene may n~t be
mediated through the .E2, binding motif. Th e E7 gene produ ct
may be a general inhibit or of transcription. This would
account for the negative regulation ?f t he he terologous SV 40
ear!>' promoter present in pSV2·CAT. How ever, it is possible
that the E7 gene product may have tw o ' ,separate functions,
one which gen er ally represses enha ncer activity, and another
which represses E 2 - media t ed tr anscri p tion (HPY-spe c ifi c
activity). To this end , the E7 gene product may interac t
directly ar indirectly with the E2 gene product and interfer e
with the trans-ac tivation doma in of the protei n. Alt ernatively,
the' E7 protein- may .interfere with the binding properties of
the E2 ge~e product . '. Furthe,r dele~ion 8~a lysis studies
required (1) to detennin e which cis-acting seque nces (Ie. the -.
" .~
. ., ~
".
' ,-p,(--". -.' , ,:.,. '.
"
, " . ~ .'
? E2 blndlng motif) ' if
repress ion and (2) to
~acti~ation or binding
repression by the E7
' "~ .~ :-?:~.":- ; : ;~ :~ : '<\ '~:"_ .:f~(~t ":-,;1': ".. j.?>:';::... .,,':::.; ;\~,
any,", required / ;. Irans
determine if direct repir SS!On . of E2
function s are involved .in the trans-
"
gene product. In particul ar, expe riments
cells expressing high er r HP V ~ constitut ive e n hancer activity
necessary ~ to examine the mechanism(s) of the E7 gene
product repress or functio~.
4:7 Viral gene regulation In HPV Infection and cancer
CollecliveQr-. the regfllts sugges t a possib le exp lanation for
the status and exPreSsion of integrate d HPV DN A in cervical
carcino mas and of · the . extrachr omosomal status o f HPV DNA
in be nign warts . or precanc~~ lesions . It has been suggested
that transcription o f the poie n tial tr a nsforming gene(s) of the
• HPY 16 E61E7 region (Be dell S<l".ill. 1987; Matlash ewskl ~ ill.
1987) is ti ghtly re gulated in benig~ war ts or preca ncerous
lesions , where . m:v DNAs arc. replica ting episomall y {Cripe .ctl.
ill. 1987). Thi~ regulation may be me d iated by th e bi?d ing of
the full -l ength E2 - t r a ns-activator and/o r ' the sho r t E2
repressor .ge n e pro d ucts to th e rep e ated E2 b inding motifs
(ACCGN4CGGT) located between the CAAT·like box and TATA
box o f Ihe,...-E6 · promoter (Fi~re 23). As discu';ed previously.
. ,
thls bin~ing . (Quid functio n to repress HPV E61E7 Fxpr~ion
~y steric hindrance. This E2 gene prod u ct(s) ~ alopg with
cellular {actors ·(which bin d to . HPY enh ancer moti fs) may also
, .. ......" ...,
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function to regulat~ other HPV promoters. In addition. ~
expression ,of the E7 ORF would res~lt in • protein ~
funedon is to rep ress E2·activa tion. This r epression may
may no t involve interfe re nce with th e bin ding of the full
length E2 gene p roduct to the upstream E2 mo t ifs.
Examination of th e physieal stale o f integrated HPV DNA
reveals that altbo~gh diff erc'nt regions of the HPV genome
were int egrate d in cerv ical c8; cinoma cell lines, the early
region including the E6 and E 7 ORFsincr conserved in
aiVrnosl cell Jines ' (B aker ,g ill.. 1987;' Pater and Paler, 1985•
.
sthwarz ,g D1 1985; Shirasa",,:' ~ B1 1988; "Ice g iL 1985).
T hese report s also indi cate th at in tegrat io n . usually occurs
• within the El ORF.. the Ef ORF. or both. The disruption of
t he 82. OR F by inte g ra tion shoul d int erte!c with trans-
regulation by t he E2 ORF produet{s). Therefo re. It would seem
thai disruption O\his gene may play. 8 rol~ in. malignant
pr ogress ion b eeeus of the deregula llo~ of E61E7 ORF
expression. Ind eed, ral transcripts In cervica l camn oma cells
appear to be prunanfy from the ~E6~and E7 O RFs (Baker ~ il.
1987; S ne id e ~ .G a llicke an d Sc hwar z. 19 8!J: Smotkin and
Wettstein, 1986). Thus, due to the de regulation o( E2:mediated
tr~n scrip t ion a1 con t rol i n c e rvica ~ cells. int~gra ttd vl;al
p romote rs are presumably activ a ted by ce ll ular transcriptional
t he . agressive ness of les ions conlaining d u plicat ions of (or
eellu ter cis-act in g regulatory eleme nts.
factors
a djacent
alone (implica~ed in Ihis study) or are enhanced by
Furthermo)e.
' I,
\
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the' < ~i ra l transcriptional enhancers ,may be. explained
by • the increased affinity for cell facto rs leading to an
increase in expression from the E6tI!? ORFs. In addition,
splicing of the HPV sequences to adjacent hU0\3n DNA and the
use of cellular polyadenylaUon sites may function to increase
the stability of E6!E7-enc od ing mRNA transc ripts. Thus,
would that integration of HPV DNA is pivota l in
producing ~ a switch in the viral transcriptional . pattern which
may . be an Important .. aspect in progression of cervical lesions
"t o malignancy. In facl , studie s HP'V -mediated
transf~rmation suggest that transformation of ~al.1 cells by
an ' E61E7 expressing construct is in most ' cases more efficient
than that observed with the entire viral genome (Bedell c.1 111.
1987). , The integration of the HPV . genome may also play a
role in cevical carcinogenesis via the HPV enhancer-Induced"
activation of adjacent oncogenes (Durst .1<1 ill. 1987a;" Swift .t1
ll!, 1987).
The recently reported homology between the oncogene c-
jun. and the transcriptional factor AP-l has pro vided the
st rongest . basis to date for the belief that transcriptional
facton; can function direct{y as oncoprotelns (Bohmann ~ 1l1,
1987; vermes , "1987: Short, 1987). Furthermore; the repressor
function of the -E1a gene pr~duct of adenovirus is tightly
ad>ci~ted with the" transforming ability of . this gene (Lillie t1
. al. 1986). " Si milarly, It is possible that vi ra l-induced
j
transcriptional repr ession . andlor ac tivatio n plays 'ce ntr a)
"I. ' ,
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ro lc in E6/E7 -nredla tcd transformation of HPV infected
cervical cells. Several pieces of evidence support this pro~'
First, the proteins encoded by the E6 and E7 ORFs contain a
common cysteine doublet (Cys.X.X jYs; ~E' any amino . acid)
repeated at- regular . intervals alorJflf' the sequence (Danos g f!1,
1984; Danos and Yaniv, 1987). Sequences of the form Cys-X-X-
eys -X( 13 j -Cy s-Xc X-Cys have also be en found in the
adenovirus E la gene products (Berg, 1986). A number of
eukaryotic nucleic acid bi.nding proteins have recently been
shown 10 contain si~ilar repeated units which are believed to
sequest er an atom of heavy metal, thereby forming a loop or
"finger" with the ability to interact with lJ!!A or RNA (Berg,
1986). Int erestingly, the association of the "finger" structure
}.'th. tran~criptiona l regulation .js : so welt accepted ' that the
~ence of this motif i~ conside red diagnosti,c , of a
t ra nscr iptiona l factor (Evans and Holle.nberg, 1988). Second,
the E7 gene product of HPV 16 and the adenovirus Elagene
pr bduct(s) share co nside ra ble fun ct ion al ho mo togy. For
instance, the Ela gene product of adenovirus can repress the
enhancer function of HPY ~8 (Swif~ ~ a1 1987; Thierry g a1
1981b), . while as reported ' here, , the E7 gene product can
repress ~PV-specific transcription. II addition, the E7 ' gene
product is known to stimula(e .expression from the adenovirus
. E2 . gene ~PhelpS'". Yet and Howley, in abstracts · of papers
p resented at th e Sixth Inter national Works hop , 1981) .
Similarly, the Eta protein(s) function to activate the rate 'of
136 0; II,
several adenovirus early genes (Be\k <l Il!.
and S~enk. 1979). In addition, results of the
present study indicate" that - - t~e early pr~moter of SV40 is also
repressed by the E7 ORF of HPV 16. Repression of . the early
~
promoter . of SV40 by the Ela gene "product is also well.
ocum nted (Borrelli '-1 aL 1984: Velcick and Ziff, 1985).
Interestingly, sequ ence closely related to the
sequence (GTGGtA:rO) ' in the SV40 enhancer "elements is also
found in the enhancers of HPV 16, 18, and 11. It remains to
be seen whether , the repressor function of the E7 ORF of HPV
, 16 is mediated through this consensus sequence,
Localization of a tran s-acting function to the "E6 gene
product of HPV I 18 and an E6-inducible enhancer to the HPV
'-"'" . 18 non coding region [Gius " ~ ilL 1988) provides additional
evidence for the involvement of transcriptional regulation in
cervical carcinoge nesis. The gene - products from the ' E6/E7
) .
re g ion of HPV 16 a nd 18 sufficient to induce
transformation of rat cells (Bedell ~ ill. 1987; Matlashewski ,g
iL 1987). . Th ese data, taken together, suggest that the
oncogenic effecr of the HPV .f.6iE7 proteins may work through
tra nscriptional rep ression /activation o{ cellula r genes involved
in ~owth regulation.
4.8 Future sludles
Results presented in this thesis suggest further studies that
'-....-
may sbed light on the molecular mechanism(s) of viral (HP,?
transcriptional . regulation.
' ( I) Site and delet ion mutagenesis of the HPV ncr should be
performed to determine :
(a) whether or not there is a negative regulatory element
.
downstream of the HPV 16 and 18 constitutive enh ance r.
(b) the enhan ce r sequence s which are requ ired for HPV
promoter function.
(e) the enhancer mqtifs (short DNA sequences) "required for
consti tutive en hancer func ion.
(2) Cell -specific cnhane a ct ivity is known 10 involve tile
inte ra ctio n of cellular transcription8~ fac tors wit h enhancer "
motifs . Fut ure sludi~s t hould atte mpt 10 de te rmine whethe r
there are ubiqui tous and cel t-specific factors binding to the
HPV enhancer an/or the putative negative regulatory element, --J
(3) The mechanism of E7-mediated 'repression may involve
binding or the E1 gene prod uct to a sequence present in the
HPV ncr. Alternatively, this repr ession may act· via art' indirect '
pathway. To Investigate whether or not ~e E7 gene product
binds to a scq ucnce( s) wit hin the HP V · non coding regiq,n,
expe ri me nts usin g tec h niqu es such ge l . ret ard ati on and
DNase I rootprinting should be co~sidered.
"'~ ,.:: . ',.:.~ :.l..': ~ .•'...
; "
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APPENDIXA
A brief description of the plasmids constructed in this study:
...
Pr1s"IID VECTOR (SITE) HPV TYPE FRAGMENT"
'p2 pSVO-CAT (HindIII) 11 DraIIlISfaNI (+)
(7486 to II')
p4 pAIO-CAT (Bglll) 16 BamHI/Avali (-)
(6150 to 112)
pS pAlO-CAT (BgllI) 11 Dralll/SfaNI (-)
p6 pAlO-CAT (Bglll) n DraIll/SfaNI (+)
p7 pAlO-CAT (Bglll) 16 BamH~all (+)
p8 pAlO-CAT (Bglll) 18 BamH amHl (+ )(6929 10 119)
p9 pAIO-CAT (Bglll) 18 BamHl/BamHI (-)
pl' pSVO-CAT (H indIII) '11 "DrallIJSfaNI (.)
pIS " pSVO-CAT (Hi ndIII) 16 BamHIIAvall ( +)
pl 7 pSVO-CAT (HindIII) 16 BamHIIAvall (.)
p29 pSVO-CAT (HindIII ) 18 . Bam.Hl/BamHI (+)
pD-2 pSV2- pMLb 16 ~foJ~'~~3') (+)
pD.7 pSV2. pMLb 16 ~l'O'l~'~~3') ( +)
pT.! . pAlO-CAT (Bglll) 11 NdelJSaul ( +)(7657 to 7870)
pT-2 pAlO-CAT(Bglll) 18 Sf.NVAcel (.)
(7419 to 7766)
pT-3 pAlO-CAT(Bglll) 16 ~~f:lm8) (+ )
pT-4 pAlO-CAT(Bglll) 18 BamHJlAcci (.)
(6929 to 7766)
pT:1I pAlO-CAT(Bglll) 18 SfaNVAcel (+)
..': " ~,. ",
·'
-, .- ' '''' :',j, .'-": ", :: " , ~ ;"i ~ '"
ISS
,OJ
.
PLASMID vscroa (SITE) HPV TYPE FRAGMENT'
pT·13 pSVIl-CAT (HindllI) 18 BarpHl/BamHI (-),
pT.18 pA lll-CAT (BgllI) 18 RsallRsal (-)
(7SOS to 7738)
pT-20 . pSV2. pMLb 16 ~bOl:~431;4) (+)
pT-25 pA11l-CAT (BglII) 11 DrBIlIlSauJ (+) ,
(7486 10 7870)
pT·28 pSVIl-CAT (H;nd llI) 18 B~sH I I/BamHI (./+)d
(7572 10 119)
pT·29 pSVIl-CAT (H;nd lll{ 18 BssHII/BamHI (+)
pT.33 pAIIl-CAT (BglII) 18 BalllHIlBbvl (+ )
(6929 In 7837)
pT.37 pAlll-CAT (BglII) 18 Bssl:lII/Acci (.j
(7572 to 77(6)
pT.39 pAlO-CAT (BglII) 18 BamHI/Avll1I (+)
(6929. 10 56)
pT-42 pAlll-CAT (Xbn l) , [SV40J (~:~'¥:i~~~ '~ p 27)-'>
pT-46 pAIIl-C',\T (BglII) 18 BamHI/Accl (+)
pT-48 pSV2- pMLb 16 rf~'~a4~~4) (+) ,J
pT-SO pAIIl-CAT (BglII) 16 ~~I~W :gl~778) (+) #
pT·SI pAlll-CAT (Xbal) [SV4UJ PvulIll-lintlll1 (+)
pT·S2 pAIIl-CAT (Xbal) 18 SfuNIIAccl (.),
pT·S3 pAIIl-CAT (Xbnl) 18 SfuNl/Acci (+)
pT·S7 pSV2- pMLb 16 Hga lllSfaNle (+)
(S I 10 4334)
pT·69 pAIIl-CAT (Bglll) 16 ~¥liq 1~1~778) (+)
pT-81 pAIIl-CAT ,(DgIII) 18 R~al/Rsll' ( + )
", . ", ~ ,, ; ~ ,' ;,
.
The HPV 16, IS. and 11 restriction enzyme sites are given in
Figure 3. P 32; (+ ) and (-) represent the o~Dtation 6f the
fragmenL
b ..
The vector pSV2-, pML was obtained by digesting '1'"pSV2-NEO-
pML with HindUl and EooRJ (found in approximately the
~ -Ib:iti°WooUIJEmRI ~?: f:~: ~led pS~T ~~nt 2.~J:
reverse tr anscr tptase. The HpalIlSauI .fragments were . then
cloned into this vector with the SV40 regulatory region and
the HPV 16 ORFs in the sam orientation.
d
. o~~tati~~HI¥:-Ia~Je (7~~2 C~'r,77~her~~~gm~~~ jSA~~a~BI OP~~ent
~ in ! hc positive•
e
There is a deletion of 635 bp in the HPY 16 sequences
(HpaIllSauI fragment) at the NdeI sites 3126 and 3761.




